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Proline metabolism is known to be involved in many cellular processes such as
cell signaling, cellular redox balance, and cell survival. One of the enzymes involved in
proline catabolism, proline utilization A, plays a role in oxidizing proline to glutamate in
a two-step oxidation pathway involving enzymes proline dehydrogenase (PRODH) and
∆1-pyrroline-5-carboxylate dehydrogenase (P5CDH).
Intermediate P5C/GSA has been shown to use an intramolecular channel to move
from the PRODH active site to the P5CDH active site in a phenomenon called substrate
channeling. In this work, one of the main objectives was to learn more about the channel
usage. Chapter 2 demonstrates that making mutations along the channel can impede
passage of intermediate, and helps describe how P5C accesses the P5CDH domain.
A second objective was to gain understanding of the structure-function
relationship of the DNA-binding domain of trifunctional PutAs. Chapter 3 discusses how
a chimera enzyme was created by attaching the DNA-binding domain of a trifunctional
PutA to a bifunctional PutA in order to make an artificial trifunctional PutA. These
results help to better understand how the DNA-binding domain orientation is important
and provide clues that more residues from the DNA-binding domain may be necessary
for DNA-binding in vivo.

Chapter 4 explores a new ubiquinone analog, and provides kinetic evidence
suggesting it is a substrate for the PRODH domain.

Additionally Geobacter

sulfurreducens was kinetically characterized and was shown to substrate channel.
Collectively, this dissertation aims to provide a further understanding of usage of
the substrate channel in proline oxidation and insight into the structure-function
relationship of trifunctional PutAs and functional switching.
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CHAPTER 1

Introduction: Substrate Channeling in Proline
Metabolism

Note: Much of this chapter has been published as a review article: “Substrate channeling
in proline metabolism.” Arentson BW, Sanyal N, Becker DF. Front Biosci.
Biosci 2012 Jan
1;17:375-88.
88. Frontiers in Bioscience granted permission for use in dissertation.
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INTRODUCTION
It is well known that proline metabolism has important roles in carbon and
nitrogen flux and protein synthesis. Proline metabolism has also emerged as a relevant
pathway in other processes such as cell signaling, cellular redox balance, and apoptosis
(1-3). Proline homeostasis is important in human disease, where inborn errors in proline
metabolism are thought to lead to neurological dysfunctions such as schizophrenia and
febrile seizures, as well as errors in systemic ammonia detoxification and developmental
disorders such as skin hyperelasticity (4-7). Recently it was shown that mutations
disrupting proline biosynthesis are linked with progeroid features and osteopenia that are
part of the autosomal recessive cutis laxa syndrome (8). In bacteria and plants, proline
metabolism is responsive to various environmental stresses such as drought, osmotic
pressure, or ultraviolent irradiation leading to proline accumulation as a survival
mechanism (9-11). Overall proline has become a very important metabolite that is
thought to be involved in many cellular processes.
Fundamental to understanding the roles of proline metabolism in various
processes is knowledge of the relevant enzymes and mechanisms used to maintain proper
proline homeostasis. In this chapter, the unique aspect of substrate channeling in proline
metabolism will be explored. Insights into the channeling mechanisms of enzymes
responsible for the catabolism and biosynthesis of proline are helping to reveal the many
roles of proline within the cell. Reviewed here are the structural and kinetic data that
support substrate channeling of P5C/GSA and γ–glutamyl phosphate in the proline
catabolic and biosynthetic pathways, respectively. The data indicate that both
intermediates are channeled, which increases the efficiency of proline metabolic flux.
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PROLINE METABOLIC ENZYMES
Proline Catabolism
The catabolic and anabolic reactions of proline metabolism are shown in Figure 1.
The catabolic pathway generates glutamate from the four electron oxidation of proline,
which occurs in two catalytic steps (12). In the first step, proline dehydrogenase
(PRODH; EC 1.5.99.8) uses a flavin adenine dinucleotide (FAD) cofactor as an electron
acceptor to remove two electrons from proline, rendering the intermediate ∆1-pyrroline-5carboxylate (P5C). P5C then undergoes a non-enzymatic hydrolysis, which opens the
ring structure and generates glutamate-γ-semialdehyde (GSA). Pyrroline-5-carboxylate
dehydrogenase (P5CDH; EC 1.5.1.12) next removes two additional electrons from GSA
using nicotinamide adenine dinucleotide (NAD+) to complete the conversion of proline to
glutamate (12).
The PRODH and P5CDH enzymes involved in the oxidation of proline are highly
conserved in both eukaryotes and prokaryotes, but differ in whether they are fused into a
bifunctional enzyme called proline utilization A (PutA). As reviewed by Tanner,
PRODH enzymes can be divided into three branches (Figure 2) (13). One branch
consists of monofunctional enzymes, where the PRODH and P5CDH domains are found
as separate enzymes. The other two branches contain the PRODH and P5CDH domains
on a single PutA polypeptide (13). Originally it was thought that all prokaryotes contain
bifunctional PutAs, and that all eukaryotes contain monofunctional enzymes. However, it
is now known that Gram-positive bacteria generally contain monofunctional enzymes,
thus limiting PutAs to Gram-negative bacteria (14).
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Proline
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Figure 1: Reactions of the proline metabolic pathway. In the catabolic pathway, proline
is converted to glutamate via a four electron oxidation process. Proline dehydrogenase
(PRODH) performs the first oxidative step, resulting in the intermediate pyrroline-5carboxylate (P5C). P5C is subsequently hydrolyzed to glutamate-γ-semialdehyde (GSA),
which is then further oxidized by P5C dehydrogenase (P5CDH) to generate glutamate. In
Gram-negative bacteria, PRODH and P5CDH are fused together on a bifunctional
enzyme called proline utilization A (PutA). Proline anabolism begins with
phosphorylation of glutamate by γ-glutamyl kinase (GK) to generate γ-glutamyl
phosphate (γ-GP). γ-GP is reduced by γ-glutamyl phosphate reductase (GPR) to GSA ,
which cyclizes to form P5C. P5C is then reduced to proline via pyrroline-5-carboxylate
reductase (P5CR). In higher eukaryotes such as plants and animals, GPR and GK are
fused together in the bifunctional enzyme pyrroline-5-carboxylate synthase (P5CS).
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Figure 2.. Phylogenetic tree ooff PutA/PRODH/P5CDH enzymes. Proline catabolic
enzymes are divided into three branches: branch 1 and branch 2 PutAs and
monofunctional PRODH/P5CDH. The monofunctional branch can be further subdivided
into bacterial and eukaryotic PRODH/P5CDH. Figure ada
adapted from (15)).
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PutA Family

As mentioned above, PutAs are divided into two branches. Branch 1 PutAs
include α, β, γ proteobacteria, while branch 2 is composed of Gram-negative
cyanobacteria, δ and ε proteobacteria, and corybacterium (15). Normally branch 1 and
branch 2 PutAs share sequence identities of less than 30%, suggesting significant
diversity between branches (16). Based on amino acid sequence and domain
organization (Table 1 and Figure 3), branch 1 and branch 2 can be further subdivided into
five different subfamilies 1A, 1B, 1C, 2A, and 2B (15). Branch 1A and 2A are composed
Table 1. PutA subfamily organization and characteristics*
Subfamily

Phylogenetic
Branch

Functional
Designation

1A

1

Bifunctional

1B

1

Bifunctional

1C

1

Trifunctional

2A

2

Bifunctional

2B

2

Bifunctional

Functional
Domains
PRODH,
P5CDH
PRODH,
P5CDH, CTD
RHH, PRODH,
P5CDH, CTD
PRODH,
P5CDH
PRODH,
P5CDH, CTD

Representative
Member

Oligomeric
State

BjPutA

Tetramer

RcPutA

Monomer†

EcPutA

Dimer

GsPutA

Dimer‡

HpPutA

Dimer‡

*Table adapted from (15).
†

Data described in Chapter 3 of this thesis.

‡

Dr. John Tanner, personal communication.

of minimalist bifunctional PutAs that only contain PRODH and P5CDH, ranging in size
from 980-1100 amino acid residues (15). Bradyrhizobium japonicum PutA (BjPutA, 999
AA) is a branch 1A example from literature that has been characterized both structurally
and kinetically and will be the focus of Chapter 2. Branch 1B and 2B consist of long
bifunctional PutAs that contain an additional ~175 residue C-terminal domain (CTD)
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Figure 3: Domain mapping of PRODH and P5CDH from E. coli (EcPutA), B.
japonicum (BjPutA), and T. thermophilus. In PutAs, the PRODH and P5CDH domains
are connected by a linker region ((L). Trifunctional PutAs such as EcPutA also have a
DNA binding domain (D).
). TtPRODH and TtP5CDH are separate enzymes
(monofunctional) in the Gram
Gram-positive bacteria, T. thermophilus. Figure adapted from
(17).
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of unknown function. Long bifunctional PutAs normally contain between 1100-1200
residues (15). Rhodobacter capsulatus PutA (RcPutA, 1127 AA) is a representative PutA
from branch 1B and will be the focus of Chapter 3. Branch 1C consists of trifunctional
PutAs that contain the PRODH, P5CDH, and CTD, but are distinct from all other PutAs
by the addition of a DNA-binding domain at the N-terminus. Trifunctional PutAs are
generally 1300-1400 residues in length (16). The DNA-binding domain is composed of a
ribbon-helix-helix (RHH) domain that interacts with the put control region and will be
discussed shortly (18, 19). E. coli PutA (EcPutA, 1320 AA) is a highly studied member
of the trifunctional PutA subfamily. As previously mentioned, eukaryotes and many
Gram-positive bacteria express PRODH and P5CDH as separate enzymes. Typically
monofunctional PRODHs are between 200-600 amino acids, while monofunctional
P5CDHs are 400-600 residues. The evolutionary divergence from bifunctional PutA to
monofunctional PRODH and P5CDH is of interest due to substrate channeling between
the active sites of PutAs. Substrate channeling between monofunctional enzymes would
necessitate functional PRODH-P5CDH interactions which have not yet been reported.
Structural Characterization of PutAs
Currently, only one three-dimensional structure of a full length PutA has been
published--the minimalist bifunctional PutA from Bradyrhizobium japonicum (BjPutA)
(PDB ID 3HAZ) (20). However, the full-length structure of a second minimalist PutA
from Geobacter sulfurreducens (PDB ID 4F9I) has been deposited in the Protein Data
Bank. The X-ray crystal structure of BjPutA provided the first structural details about
domain organization and overall arrangement of PutAs. Truncated EcPutA structures
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have also been solved of the PRODH domain of EcPutA (PDB ID 1K87, 1TJ2, ITIW,
1TJ0, 3ITG), but the entire structure of a trifunctional PutA remains elusive (21-24).
Additionally, the RHH DNA binding domain was solved by solution NMR
(Pseudomonas putida, PDB ID 2JXI, 2JXG) and X-ray diffraction (E. coli, PDB ID
2GPE, 2RBF) (25-27). Though a full length trifunctional structure does not exist, smallangle X-ray scattering (SAXS) was used to determine the 3-dimensional molecular
envelope of EcPutA (28). Additionally, several structures of monofunctional PRODH
and P5CDH exist, including PRODH from Thermus thermophilus (2G37) and
Deinococcus radiodurans (PDB ID 4H6R) and P5CDH from human (PDB ID 3V9G),
mouse (PDB ID 3V9J), and T. thermophilus (PDB ID 1UZB) (29-32).
Crystal structures of BjPutA and EcPutA both show the PRODH active site is
located within a distorted (βα)8 barrel, where the re face of a non-covalently bound flavin
is packed against the barrel, leaving the si face accessible for substrate binding and
catalysis (Figure 4) (20, 22).

As mentioned, trifunctional PutAs also contain a DNA-

binding domain composed of a RHH domain that provides the point of dimerization (21).
The P5CDH active site is found at the interface between a Rossmann-like NAD+ binding
domain and the activity domain that provides the catalytic cysteine (28).
While the active site domain folds are thought to be conserved throughout the
PutA superfamily, the oligomeric structures are not conserved. Within branch 1A, the
oligomeric state of minimalist PutAs BjPutA and Legionella pneumophila (LpPutA) are
tetrameric and dimeric, respectively (15, 20). In branch 1B, SAXS data suggests RcPutA
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Figure 4: PRODH active site from EcPutA (residues 86
86-669)
669) coordinating proline
analog L-tetrahydro-2-furoic
furoic acid (THFA). The re face of flavin is shown packed against
the (βα)8 barrel, exposing the si face to substrate catalysis. R556 is an active site residue
known to coordinate the carboxyl group of proline for catalysis. Flavin is colored in
yellow, THFA in green, and R556 in yellow. Black dashed lines represent hydrogen
bonds
onds between R556 and THFA and flavin. Figure generated using PDB code 1TIW and
PyMOL (23).
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is a monomer, while branch 1C representative EcPutA is a dimer (28). However, early
evidence suggests more parity within branch 2, as representatives of subfamilies 2A (G.
sulfurreducens) and 2B (H. pylori) are both dimers (Tanner, personal communication)
(15).
A β-hairpin extending from the NAD+ binding domain may provide some clues
about the oligomerization state in PutAs. The β-hairpin, along with a C-terminal β-strand
form a point of dimerization through domain swapping for minimalist PutAs, as well as
all other aldehyde dehydrogenases (15). However, in long bifunctional and trifunctional
PutAs, multiple sequence alignments indicate the β-hairpin is truncated or nonexistent
(16). Due to this truncation, it is unlikely that dimerization through domain swapping
occurs in long bifunctional PutAs and trifuncational PutAs. This has been verified in
trifunctional PutAs, which dimerize though the RHH domain as well as the long
bifunctional PutA member RcPutA, which is monomeric (described in Chapter 3).
Trifunctional PutAs and Functional Switching
Early work on Salmonella typhimurium revealed that PutA is a membrane bound
flavoprotein and also a negative regulator of the put operon (33, 34). Later, it was shown
that PutA interaction with the put control region was abolished by two conditions, when
proline and either an electron acceptor or membrane was present or when the flavin was
reduced by dithionite (35). Around the same time, work on the E. coli PutA enzyme
indicated functional switching from a DNA-bound state to a catalytically active,
membrane bound state occurred via a redox dependent mechanism (36). Parallel with this
observation were chymotryptic digestions of E. coli PutA (EcPutA) in the presence and
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absence of proline that revealed different digestion patterns (37). Therefore, it was
hypothesized that the binding of proline in the presence of a flavin electron acceptor
induces a conformational change and, under these conditions, PutA becomes more
hydrophobic leading to enhanced membrane association and catalysis (35, 38).
Membrane association and DNA-binding were shown to be two mutually exclusive
events that are dependent on environmental proline levels. When proline levels are low,
PutA remains in the cytoplasm where it interacts with the put control region and represses
expression of putA and putP (a high affinity Pro/Na+ symporter) genes (39). When
proline levels increase, PutA associates with the membrane where it becomes
catalytically active (39). The conformational change was shown to be reversible, as
catalytically active enzyme could be re-oxidized and lose its ability to interact with the
membrane (40). Thus, the interaction between the DNA-binding domain and the put
control region is dependent on environmental proline levels, linking transcription to
metabolism.
Alongside proteolysis experiments, structural evidence also supports both global
and redox-dependent conformational changes in PutA. An X-ray crystal structure of the
PRODH domain of EcPutA treated with sodium dithionite revealed structural changes in
the flavin adenine dinucleotide (FAD) cofactor. The isoalloxazine ring of the FAD was
observed to be bent 22° along the N(5)-N(10) axis, whereas the ring is planar when the
FAD is oxidized. In addition, the ribityl chain was rotated and a new hydrogen bond
network was formed between ribityl hydroxyl groups and the surrounding residues in
PutA (41). Similar changes in the flavin and the surrounding hydrogen bond network are
also seen when inactivating the PRODH domain with the mechanism-based inhibitor N-
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propargylglycine (PPG) (24). The conformational change in the ribityl moiety caused by
dithionite is thought to help inititate global conformational changes in PutA that
ultimately leads to functional switching between DNA and membrane binding. Recently
it was reported that the β3-α3 loop of the PRODH (βα)8 barrel domain of EcPutA is part
of the electrostatic network disrupted upon flavin reduction, and may be involved in
propagating the flavin redox state to the peripheral membrane binding domain (42).
Mutating β3-α3 loop residue D370 to alanine or asparagine disrupted functional
switching, allowing EcPutA to associate with the membrane in the presence and absence
of proline (42). Crystal structures of the mutants reveal no significant changes in the β3α3 loop region or within the PRODH domain, concluding that the mutants disrupt the
flavin redox signal transmission to peripheral regions of PutA. It should be noted that
outside the β3-α3 loop region, little else is understood regarding how the conformational
change radiates from the reduced flavin to the rest of the enzyme (43).
Proline Biosynthesis
Proline biosynthesis from glutamate involves three enzymatic steps (Figure 1).
The initial two steps are catalyzed by γ-glutamyl kinase (GK; EC 2.7.2.11) and γglutamyl phosphate reductase (GPR; EC 1.2.1.41). GK uses adenosine-5’-triphosphate
(ATP) to generate γ-glutamyl phosphate, which is subsequently reduced by GPR using
nicotinamide adenine dinucleotide phosphate (NADPH) to produce GSA (12). GSA next
cyclizes to P5C, which is a crossroads intermediate that, in principle, can be converted
not only to proline, but also to ornithine or back to glutamate via P5CDH (12). The
reduction of P5C to proline is catalyzed by P5C reductase (P5CR; EC 1.5.1.2), while the
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production of ornithine from P5C requires ornithine aminotransferase (OAT; EC
2.6.1.13), an enzyme that is important for balancing cellular nitrogen levels (12).
In bacteria and lower eukaryotes such as yeast, GK and GPR are discrete
monofunctional enzymes. In animals and plants, the GK and GPR domains are fused
together into the bifunctional enzyme P5C synthase (P5CS) (Figure 5). The GK and
GPR domains are well conserved in lower eukaryotes and bacteria. The GK domain is
normally between 250-450 residues in length with an N-terminal amino acid kinase
(AAK) domain. In bacteria, GK contains a C-terminal pseudo uridine synthase and
archaeosine-specific transglycosylase (PUA) domain, which has no known function (44).
It has been suggested, however, that the PUA domain may enable bacterial GK to have a
gene regulatory role (45). The structures of GK enzymes from E. coli and
Campylobacter jejuni have been solved (PDB ID 2J5T, 2AKO) (46). E. coli GK is
composed of an N-terminal catalytic domain made up of eight nearly parallel β-sheets
sandwiched by two layers of three and four α-helices. It is connected by a linker region
to the PUA domain, which contains a distinctive β sandwich (46).
GPR typically contains 400-500 residues and consists of an N-terminal Rossmann
fold domain for NADPH binding, a catalytic domain, and an oligomerization domain at
the C-terminus (47). The X-ray crystal structure of GPR from Thermotoga maritima
reveals that the catalytic domain has an α/β architecture with a five-stranded parallel βsheet (PDB ID 1O20) (47). To date, no complete structure of bifunctional P5CS has been
reported. However, the structure of the isolated GPR domain (PDB ID 2H5G;
unpublished) from human P5CS is available. The last enzyme of the proline biosynthetic
pathway, P5CR, ranges from 400-500 residues in length and has a conserved N-terminal
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Figure 5: Domain mapping of monofunctional γ-glutamyl phosphate reductase (EcGPR)
and γ-glutamyl kinase (EcGK) enzymes from E. coli and bifunctional pyrroline-5carboxylate synthase (P5CS) from Homo sapiens. M, putative mitochondrial signaling
peptide, BD, binding domain for glutamate and ATP, O, oligomerization domain, and
PUA, pseudo uridine synthase and archaeosine-specific transglycosylase domain with no
known function in EcGK. Figure adapted from (17).
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Rossmann fold for NADPH binding. Several crystal structures of P5CR have been
determined including the human form (PDB ID 2GRA) (48). Human P5CR has an active
site cleft made of an 8-stranded β-sheet sandwiched by α-helices on either side and
oligomerizes to form a decameric structure of dimers (48).
INTERMEDIATES OF PROLINE METABOLISM
The P5C/GSA and γ–glutamyl phosphate intermediates of proline metabolism are
appreciably labile and reactive. Figure 6 shows examples of undesirable fates that can
occur with these intermediates. The instability of the intermediates implies substrate
channeling may be important for maintaining efficient proline metabolic flux. The
intermediate shared by the catabolic and biosynthetic pathways, P5C/GSA, has been
shown to inhibit other enzymes, react with metabolites, and act as a signaling molecule.
GSA has been reported to inhibit glucosamine-6-phosphate synthase from E. coli,
cytidine 5’-triphosphate synthase, and the amidotransferase domain of carbamoyl
phosphate synthetase (49-51). Additionally, P5C forms adducts with other metabolites
such as pyruvic acid, oxaloacetic acid, and acetoacetic acid (52). P5C can also react with
pyridoxal phosphate in patients with type II hyperprolinemia. Type II hyperprolinemia is
characterized by elevated plasma levels of P5C/GSA due to deficient P5CDH activity
(53). The high levels of P5C/GSA generates inactive adducts with pyridoxal phosphate,
leading to lower amounts of functional vitamin B6 in patients (Figure 6) (52). P5C also
acts as a signaling molecule in eukaryotes and is thought to induce apoptosis by
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Figure 6: Side reactions of intermediates pyrroline-5-carboxylate (P5C) and γ-glutamyl
phosphate (γ-GP). (A) P5C can deactivate pyridoxal phosphate by forming an adduct,
resulting in vitamin B6 deficiency in individuals with hyperprolinemia type II. The P5Cpyridoxal phosphate adduct structure is from reference 38. (B) γ-GP can cyclize and
dephosphorylate to form 5-oxoproline, which is suggested to be a neurotoxin in rats.
Figure adapted from (17).
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increasing intracellular reactive oxygen species (54, 55). Altogether, it seems that
controlling levels of free P5C/GSA would be beneficial.
The reactive intermediate in proline biosynthesis is γ–glutamyl-phosphate. The
carbonyl phosphate group is susceptible to nucleophilic attack, resulting in the
spontaneous cyclization of γ–glutamyl-phosphate into 5-oxoproline as shown in Figure 6
(56, 57). It has been suggested that 5-oxoproline is a neurotoxin. Interstitial injection of
5-oxoproline into rats produces behavioral and neuropathological effects that resemble
Huntington’s disease (58, 59). The instability of γ–glutamyl phosphate seems to
necessitate its channeling between GK and GPR during proline biosynthesis.
OVERVIEW OF SUBSTRATE CHANNELING
Rationale for Substrate Channeling
Substrate channeling is a phenomenon where the product of one reaction is
transported to a second active site without equilibrating into bulk solvent (60). Three
mechanisms of substrate channeling have been defined, two of which are reviewed by
Miles et al. (61). The most common form of substrate channeling occurs when a cavity
exists within a protein that sequesters the intermediate from solvent, allowing for a means
of travel between active sites (61). To date, several enzymes are known to utilize these
intramolecular tunnels, with the classic example being tryptophan synthase (62). The
second form of channeling does not use intramolecular cavities; rather, electrostatic
residues on the surface of the enzyme guide the intermediate from the first active site to
the second active site (61). Dihydrofolate reductase-thymidylate synthase complex
stands as the common example for this form of channeling (63). A third form of

19
channeling exists in protein complexes such as pyruvate dehydrogenase, which uses
cofactor lipoic acid to transfer substrate to multiple active sites without contacting solvent
(64).
Substrate channeling has been proposed to be advantageous in the cellular
environment for several reasons, as outlined by Ovadi and others (60, 65). First and
foremost it increases the efficiency of coupled reactions both by preventing the loss of
intermediates to diffusion and by decreasing transit time between active sites. This allows
the steady-state flux through the coupled steps to be attained more rapidly (60).
Secondly, it prevents labile intermediates from decaying and reacting with other
metabolites or enzymes within the cell (60). Third, channeling segregates intermediates
that may require a specific environment (e.g., pH) to retain structure or reactivity.
Channels can provide an environment that facilitates an equilibrium step that normally
would be unfavorable in the bulk solution. Finally, channeling limits intermediates from
being siphoned out into competing reactions or pathways (60).
All of the benefits listed above are not necessarily relevant for every channeling
system. In the proline catabolic pathway, channeling of P5C/GSA may be most critical
for making the hydrolysis of P5C to GSA more favorable at physiological pH. The
P5C/GSA equilibrium is highly pH dependent (49). GSA is favored only below pH 6.5
due to protonation of the pyrrolinium ring, which facilitates the hydrolysis of P5C to
GSA. Thus, one benefit of channeling between PRODH and P5CDH would be to
increase the pKa of the pyrrolinium species above pH 6.5, making the hydrolysis of P5C
to GSA more favorable at physiological pH. If we only consider the P5C/GSA hydrolysis
step, substrate channeling is likely more critical for the proline catabolic pathway than for
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proline biosynthesis, since P5C formation is favored at physiological pH. In the proline
biosynthetic pathway, protecting the highly labile γ–glutamyl phosphate would be a clear
benefit of substrate channeling between GK and GPR.
Kinetic Approaches to Test for Substrate Channeling
Different strategies have been devised to examine whether channeling occurs
between enzymes. Before reviewing the evidence for substrate channeling in proline
metabolism, a short description of various experimental methods is described here.
Transient Time Estimation
A common strategy to test for channeling is to evaluate whether there is a lag time
in reaching steady-state formation of the final product in a coupled assay. Figure 7 shows
substrate (S) being converted to the final product (P) via the coupled action of two
enzymes (E1 and E2). The lag time or transient time, Tau (τ), is the time preceding the
build-up to steady-state formation of the final product using the substrate of the first
enzyme (66). If no channeling occurs, τ should be equal to the ratio of Km/Vmax of the
second enzyme. If the observed lag time is shorter than the Km/Vmax ratio, then it infers
that the intermediate is transferred between the enzymes, E1 and E2. The extent of the
observed lag time may vary among different channeling systems with a shorter transient
time being interpreted as more efficient transfer or channeling (67). Along with steadystate assays, pre-steady state measurements can also be made to evaluate the lag time
prior to product formation.
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Figure 7: Strategies for examining substrate channeling. (A) Transient time analysis of a
coupled reaction involving two enzymes, E1 and E2, which convert substrate S into
product P. A trapping agent can also be used to test whether intermediate I is released
into bulk solvent during the reaction. (B) Inactivation of one of the enzyme pairs by sitesite
directed mutagenesis. If channeling occurs, adding inactive E2 would disrupt the active
E1-E2
E2 complex resulting in lower steady
steady-state
state activity. (C) Testing channeling in
bifunctional enzymes. Inactivation of the individual domains results in monofunctional
variants that can only catalyze the coupled reaction via a diffusion mechanism. The
mixture of monofunctional variants is thus a non
non-channeling control. Figure adapted from
f
(17).
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Trapping the Intermediate
The effect of a reagent that specifically traps the intermediate species (I, Figure 7)
on the kinetics of product formation can also be used to evaluate channeling. For
example, o-aminobenzaldehyde (o-AB) which reacts with P5C to form a yellow complex
can be used as a trapping agent for the PRODH and P5CDH coupled reaction. o-AB
would be anticipated to decrease the overall rate of glutamate formation if no channeling
occurs, while in a channeling system o-AB would have a negligible effect on the reaction
kinetics. Using a third enzyme that competes with E2 for the intermediate can also be an
effective strategy to test for substrate channeling.
Inactive Mutants
Another useful tool is to generate active site mutants of the two enzymes being
studied (Figure 7B). In the case of suspected channeling partners, an active site mutant
(e.g., E2) would be expected to compete with its native counterpart for interaction with
the cognate enzyme (E1). If channeling occurs, adding the inactive E2 mutant in amounts
excess to that of native E2 would decrease product formation. If no channeling occurs,
adding the inactive E2 mutant to the coupled enzyme assay would have no effect on the
rate of product formation. This strategy was effectively used to rule out channeling
between aspartate aminotransferase (AAT) and malate dehydrogenase (MDH) (68).
If the channeling involves two enzyme active sites that are covalently linked,
active site mutants can be used to generate a non-channeling control. Figure 7C illustrates
that combining active site mutants of E1 and E2 creates a mixture of monofunctional
enzyme variants that can only generate product via a diffusion mechanism. The transient
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times of the native enzyme and the mixed enzyme variants can then be compared to
distinguish between channeling and non-channeling mechanisms. This strategy was used
recently to demonstrate channeling in bifunctional PutA.
Designing Fusion Proteins
Two active sites that are in close proximity can sometimes exhibit kinetic
behavior that resembles direct channeling (69). One strategy for distinguishing between
active channeling and proximity effects is to change the relative orientation of two active
sites, which is important for interacting enzymes (70). A polypeptide linker can be
engineered to covalently link the two enzymes with various degrees of flexibility and in
different orientations (69). If the enzymes are truly channeling, changes in the orientation
of the active sites will have a dramatic effect on the kinetics of production formation.
CHANNELING OF P5C/GSA
The oxidation of proline to glutamate is catalyzed in consecutive reactions by
PRODH and P5CDH (Figure 1). Avoiding release of P5C/GSA into bulk solvent during
proline oxidation may be beneficial due to the chemical properties of P5C/GSA as
discussed in the previous section. Evidence for channeling P5C/GSA has recently been
shown for bifunctional PutA from BjPutA. Srivastava et al. reported a 2.1 Å resolution
crystal structure of BjPutA (999-residue polypeptide) that reveals an interior channel
connecting the PRODH and P5CDH active sites (PDB ID 3HAZ) (24). Figure 8 shows a
structural model of BjPutA, which purifies as a homodimer. Both PRODH and P5CDH
domains contribute to the formation of the channel, with the two active sites separated by
a distance of 41 Å. The connecting channel appears to start at the si face of the
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Figure 8: Structure of dimeric BjPutA shown in ribbon representation. The PRODH
domain (red) and the P5CDH domain (orange) of each protomer are connected by a
linker region (green). Active site residues (Arg456, Cys792), FAD and NAD+ are
displayed as sticks. β-flap of each protomer is colored as magenta. The substrate channel
of each BjPutA protomer is shown as blue surface. This model was made using PyMol
and PDB 3HAZ.
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isoalloxazine ring of FAD and end at the catalytic cysteine (Cys792) of the P5CDH
domain (Figure 8). Within the channel, the central cavity is lined by fifteen basic residues
(Lys and Arg) and seventeen acidic residues (Glu and Asp), imparting a hydrophilic
nature to the channel. Each of the PutA protomers has an individual channel connecting
the PRODH and P5CDH active sites.
Interestingly, the dimeric structure of BjPutA seems to be critical for sealing the
channel and minimizing access to bulk solvent. A β-flap protrudes from the P5CDH
domain (β strand residues 628-646, 977-989) from one protomer and forms
intermolecular interactions with the P5CDH domain of the second protomer (Figure 8).
This β-flap is structurally conserved in Thermus thermophilus P5CDH (PDB ID 1UZB,
residues 163-174,506-516) as well as a class I aldehyde dehydrogenase isolated from
sheep liver (PDB ID 1BXS, residues 147-159, 486-498) (71, 72). Thus, in BjPutA, the βflap not only helps stabilize dimer formation but is also important for sealing the central
cavity.
Along with these structural features of channeling, kinetic evidence for
channeling was also reported for BjPutA by Srivastava et al. (24). Different experiments
have provided strong evidence for channeling. First, the amount of P5C released into
bulk solvent was quantitated by using o-aminobenzaldehyde (o-AB) as a trapping agent.
P5C and o-AB react to form a yellow complex that can be monitored at 443 nm (73). In
the absence of NAD+, the P5CDH domain is inactive and leads to significant release of
P5C into the bulk solvent, as detected by yellow complex formation. In the presence of
NAD+, however, the P5CDH domain is active, resulting in significantly lower o-AB-P5C
complex formation, as the majority of P5C is converted into glutamate (24). The apparent
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fraction of P5C that is channeled in BjPutA from PRODH to P5CDH was estimated to be
0.7 by these measurements.
Substrate channeling in BjPutA was also examined by estimating the transient
time to reach steady-state turnover of the second enzyme, P5CDH, using proline as a
substrate (24, 74, 75). With native BjPutA, steady-state formation of NADH (product of
the P5CDH reaction) occurred without any apparent lag time (24). The absence of a lag
time in the approach to steady-state indicates substrate channeling. A non-channeling
control was also analyzed using active site mutants of BjPutA that lack PRODH
(R456M) and P5CDH (C792A) activity (24). The R456M mutation inactivates PRODH
but does not impair P5CDH activity, whereas the C792A mutation inactivates P5CDH
but does not impair PRODH activity. The mixture of these monofunctional variants was
used as a non-channeling control as described above. In this non-channeling control, P5C
formed by the C792A variant must diffuse out into bulk solvent and bind to the R456M
variant before NADH is formed. In the assays with the non-channeling variants, a lag
time of about seven minutes for NADH formation was observed (24). The observed lag
time was similar to the theoretical τ value calculated from the independent PRODH
activity and P5CDH kinetic parameters. An example of these steady-state assays is
shown in Figure 9. Figure 9 illustrates the clear difference in the kinetic behavior of
native BjPutA and the non-channeling control. With native BjPutA, NADH formation is
observed without a lag time, while with the mixed variants a lag time of around 6.5
minutes is observed. The results from these assays are consistent with a substrate
channeling mechanism in BjPutA. Kinetic profiles of native BjPutA and the mixed
variants were also compared by rapid-reaction kinetics under anaerobic, single-turnover
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Figure 9: Example of transient time analysis of BjPutA. Steady-state formation of
NADH using proline as a substrate by native BjPutA (solid black curve) and an
equimolar mixture of monofunctional variants R456M and C792A (solid grey curve).
The mixture of the monofunctional variants serves as a non-channeling control. The
dotted line represents the extrapolation used for estimating the lag-time. Native BjPutA
shows no apparent lag in NADH formation, while a lag time of about 6.5 min is observed
for the non-channeling control. The dashed line overlaying the grey curve of the nonchanneling control reaction was simulated using the kinetic parameters of PRODH and
P5CDH as described previously and the following equation: [NADH] = v1t + (v1/v2)Km(ev2t/Km

- 1) (76). Assays were performed at pH 7.5. Figure adapted from (17).
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conditions. Rapid mixing of native BjPutA and proline generated NADH with no
apparent lag time. For the non-channeling variants, a 10 s lag time for NADH formation
was observed after mixing the enzymes with proline. These results show native BjPutA
efficiently channels P5C/GSA.
Evidence for channeling in PutA has also been reported from Salmonella
typhimurium PutA (StPutA). Similar to EcPutA, StPutA contains the N-terminal DNA
binding domain and is thus trifunctional. Maloy et al. demonstrated that the P5CDH
domain shows a 14-fold greater steady-state production of NADH using P5C generated
endogenously from proline by PRODH, as compared to exogenously added P5C (77). In
addition, they showed exogenous P5C was unable to compete against endogenous P5C.
Due to a lack of structural information on trifunctional PutAs, it is not clear whether a
channel similar to that characterized in BjPutA exists. Future structural and kinetic
experiments will need to be performed to fully address the channeling mechanism in
trifunctional PutAs.
CHANNELING OF γ-GLUTAMYL PHOSPHATE
As mentioned previously, channeling of the intermediate γ-glutamyl phosphate
would be beneficial because of its instability. Channeling of γ-glutamyl phosphate is also
implicated by the fusion of GK and GPR in bifunctional P5CS. Kinetically speaking, data
has existed for over forty years suggesting that a complex forms between bacterial GK
and GPR in order to conceal γ-glutamyl-phosphate from solvent (78, 79). A typical assay
to measure GK activity is to add hydroxylamine along with the substrates, glutamate and
ATP. Hydroxylamine reacts with the product γ-glutamyl phosphate to make γ-glutamyl
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hydroxamate, which can be measured at 535 nm (78). Multiple groups have documented
that GK activity is dependent on the presence of GPR. GK is inactive or exhibits very
low activity in the absence of GPR, suggesting GPR is required for GK activity (56, 57,
78, 80, 81). It was found that a 10:1 GPR:GK ratio was necessary to obtain maximal GK
activity, indicating that a GK/GPR complex forms with excess GPR (80). To test for a
complex, Smith et al. tried incubating different ratios of bacterial GK and GPR, then
looked for co-elution of the enzymes by chromatography (80). Both proteins eluted
separately meaning either a complex does not form or complex formation is transient and
is dependent on substrate binding. Other work suggesting a GK-GPR complex includes
assays which contained GK and GPR, but lacked NADPH, the cofactor necessary for
GPR activity (57). In this case the GPR enzyme was inactive, but it still activated GK.
GK has also been shown to be activated by incubation with GPR mutants, further
demonstrating that GK activation by GPR does not require GPR activity (82). Other
experiments that have explored GK/GPR interactions include Chen et al., who created a
mutant GK/GPR fusion protein that was able to over-produce proline, making the host E.
coli strain more resistant to osmotic stress (83). While this work does not support
channeling directly, it does show that enhancing the proximity of two active sites can
significantly increase the efficiency of a metabolic pathway (83).
Structural data supporting channeling is not directly available for GK and GPR
enzymes (84). Figure 10 shows the individual structures of E. coli GK (EcGK) and T.
maritima GPR (TtGPR). Marco-Marin et al. modeled a possible interaction between
monofunctional GK and GPR, showing GPR in both an open and closed conformation,
depending on the binding status of the substrate (46). The model shows a tetrameric form
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Figure 10: Structures of GPR from T. maritima (TmGPR) and GK from E. coli (EcGK).
EcGK is shown as a dimer with one monomer shown in surface representation and the
other monomer as a ribbon cartoon illustration. Glutamate is shown as spheres in the
substrate binding pocket, which is solvent accessible. Only one monomer of GPR (open
conformation) is shown, which contains three domains: NADPH binding domain
(yellow), catalytic domain (blue) with the catalytic cysteine shown in spheres, and the
oligomerization domain (black). The solvent-exposed glutamate binding pocket of GK
suggests that the γ-glutamyl phosphate intermediate would be accessible to GPR in a
potential GK-GPR complex. A GK-GPR complex in which the catalytic domain of GPR
is aligned with the glutamate binding pocket of GK has been proposed and modeled by
Marco-Marin et al (46). Models shown here were made using PyMol and PDBs 2J5T
(EcGK) and 1O20 (TmGPR). Figure adapted from (17).
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of GK from E. coli complexed with a dimer of GPR from T. maritime (46). In solving
the crystal structure EcGK, Marco-Marin et al. noted that GK was well suited for
channeling (46). They suggested that channeling is possible if the GK and GPR active
sites are positioned so that the active site cysteine of GPR is able to react with γ-glutamyl
phosphate while still bound at the GK active site. A complex as described would allow
for a favorable environment and timely transfer of γ-glutamyl-phosphate to the second
active site thereby preventing cyclization to 5-oxoproline (46). Additionally it has been
suggested that leucine zipper motifs found in the GK and GPR domains of plants, as well
as the GK and GPR enzymes of some bacteria are evidence for a functional complex
(85). The leucine zipper of plant P5CS may help with oligomerization or it may be an
artifact of evolution. Several domain swapping experiments have shown that leucine
zippers mediate protein-protein dimerization in eukaryotic and prokaryotic enzymes.
Thus, the leucine zippers in bacterial GK and GPR enzymes and plant P5CS may support
a possible channeling complex (86).
SUMMARY
As presented in this chapter, there is solid evidence of substrate channeling in
proline metabolism, particularly in the catabolic pathway where structural and kinetic
evidence both exist. However, there are many outstanding questions left to answer such
as must P5C use the channel to access the P5CDH domain, how does exogenous P5C
enter the cavity, and where does the hydrolysis step occur. To help answer these
questions, Chapter 2 of this dissertation will further explore the substrate channel by
making bulky mutations along the cavity to impede passage of P5C. Kinetic
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characterizations will be used to determine the effects of the mutations and whether they
change the overall structure of the enzyme, allowing conclusions to be drawn regarding
how P5C accesses the second active site. Chapter 3 helps to further understand the
structure-function relationship of the DNA binding domain and the functional switching
mechanism employed by trifunctional PutAs. An artificial trifunctional PutA was created
by fusing the DNA-binding domain of EcPutA to a monomeric, long bifunctional PutA
(RcPutA). This fusion enzyme provides further knowledge of the DNA-binding domain
and hints that more residues may be necessary to form a functional DNA-binding domain
in vivo. Finally, Chapter 4 will be divided into two parts. The first part will provide
kinetic evidence supporting a new ubiquinone analog as a functional substrate in PutAs.
It also presents kinetic results suggesting a newly purified PutA, GsPutA, also uses a
substrate channeling mechanism. The second half will kinetically explore a PRODH
domain in order to better understand how proline enters and leaves the active site.
Ultimately this dissertation will help further the knowledge of the proline metabolic field
by using steady-state kinetics to investigate different aspects of proline utilization A.
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CHAPTER 2
Kinetic Characterization of Channel
Channel-blocking
blocking
Mutants in Bradyrhizobium japonicum Proline
Utilization A (PutA)

Note: Structural evidence validating kinetic characterizations was done in collaboration
with Dr. John J. Tanner, University of Missouri
Missouri-Columbia.
Columbia. However, structural results
are not presented in this dissertation.
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ABSTRACT
Proline utilization A (PutA) from Bradyrhizobium japonicum (BjPutA) is a
bifunctional flavoenzyme that catalyzes the oxidation of proline to glutamate using fused
proline dehydrogenase (PRODH) and ∆1-pyrroline-5-carboxylate dehydrogenase
(P5CDH) domains. Recent crystal structures and kinetic data suggest an intramolecular
channel connects the two active sites, promoting substrate channeling of the intermediate
P5C from the PRODH domain to the P5CDH domain. In this work several mutations
were made along the channel in an effort to block passage of P5C to the second active
site. Analysis of several site-specific mutants in the substrate channel of BjPutA revealed
an important role for D779 in the channeling path. BjPutA mutants D779Y and D779W
significantly decreased the overall PRODH-P5CDH channeling reaction indicating that
bulky mutations at residue D779 impede travel of P5C through the channel. Interestingly,
D779Y and D779W also exhibited lower P5CDH activity, suggesting that exogenous
P5C must enter the channel upstream of D779. Replacing D779 with a smaller residue
(D779A) had no effect on the catalytic and channeling properties of BjPutA showing that
the carboxylate group of D779 is not essential for channeling. An identical mutation at
D778 (D778Y) did not impact BjPutA channeling activity. Thus, D779 is optimally
orientated so that replacement with the larger side chains of Tyr/Trp blocks P5C
movment through the channel. The kinetic data reveal not only that bulky mutations at
residue D779 hinder passage of P5C to the second active site, but also P5C must use the
channel to efficiently access the P5CDH domain. Moreover, these mutants may be used
to learn more about the hydrolysis event that is thought to take place within the channel.
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INTRODUCTION
Proline utilization A (PutA) catalyzes the conversion of proline to glutamate using
two consecutive reactions (Scheme 1). In the first step, proline dehydrogenase (PRODH)
uses a flavin cofactor as an electron acceptor to remove two electrons from proline,
resulting in ∆1-pyrroline-5-carboxylate (P5C). P5C then undergoes a non-enzymatic
hydrolysis, which opens the pyrroline ring to create glutamate-γ-semialdehyde (GSA).
GSA is a substrate for NAD+-dependent pyrroline-5-carboxylate dehydrogenase
(P5CDH), where two additional electrons are removed generating glutamate. Proline and
proline metabolism are important to all walks of life. For example, proline plays
important roles in different pathogens including pathogenicity of Helicobacter pylori and
H. hepaticus (1, 2), energy production for procyclic trypanosomes (3, 4), and regulation
of metabolites linked to pathogenesis in Photorhabdus and Xenorhabdus (5). In humans,
inborn errors in PRODH are linked to schizophrenia (6, 7). PRODH is also regulated by
p53 and has been shown to suppress cancer (8).
PutA occurs as a bifunctional enzyme in all Gram-negative bacteria and
Corynebacterium (9). A recent crystal structure of Bradyrhizobium japonicum PutA
(BjPutA) revealed a tunnel connecting the two active sites (10). Structural and kinetic
results suggest P5C/GSA uses the channel to travel from the PRODH active site to the
P5CDH active site, without equilibrating with external solvent in a phenomenon called
substrate channeling (10-12). Three different mechanisms of substrate channeling have
been identified in nature. The classic example includes an intramolecular channel
connecting two active sites. Tryptophan synthase remains the most studied enzyme using
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Proline

Glutamate
NADH + H+

FAD
FADH2

PRODH

P5CDH

NAD+, H2O

+ H2O

P5C

-H2O
GSA

Scheme 1. Overall reaction catalyzed by proline utilization A (PutA). Flavin-dependent
proline dehydrogenase catalyzes the oxidation of proline to ∆1-pyrroline-5-carboxylate
(P5C). P5C undergoes a non-enzymatic hydrolysis, resulting in glutamic-γ-semialdehyde
(GSA). Finally, GSA is oxidized to glutamate using an NAD+ cofactor and water.
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this method of channeling (13, 14). A second mechanism for channeling involves the
intermediate moving across the surface of the enzyme. Two variations of surface
channeling have been reported: dihydrofolate reductase-thymidylate synthase, which
uses a surface “electrostatic highway” (15, 16), and dethiobiotin synthetasediaminopelargonic acid aminotransferase, which uses a polar crevice along the enzyme’s
surface (17). A third mechanism of substrate channeling involves using a swinging arm
to transfer intermediate to multiple sites. The pyruvate dehydrogenase complex provides
an example where a lipoic acid cofactor acts as an arm (18).
Several physiological benefits of substrate channeling versus free diffusion have
been identified. Chiefly, channeling decreases transit time between active sites and
prevents loss of intermediates by diffusion, making the overall reaction more efficient
(11, 19). Thus, channeling enzymes can operate at maximum rates even if cellular
substrate concentrations are not at saturating levels (20). Also, labile intermediates can
be concealed from solvent to prevent decay or interaction with other molecules (13, 21).
Finally, reaction intermediates from competing reactions can be kept separate, which
dictates metabolic flux (12).
As mentioned, a crystal structure of BjPutA revealed a tunnel connecting two
active sites, which is thought to channel intermediate P5C/GSA. Theoretically, the
channeling of P5C/GSA is physiologically reasonable, as P5C is a substrate of three
competing reactions. It can be converted to glutamate via P5CDH, ornithine via
ornithine aminotransferase, or back to proline via P5C reductase. Thus, channeling of
P5C in proline catabolism may be necessary to retain proper metabolic flux and avoid
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metabolic cycling (21). Besides enzyme competition, free P5C/GSA is reported to be an
inhibitor of glutamine in three different E. coli enzymes including glucosamine-6phosphate synthase, cytidine 5’-triphosphate synthase, and the amidotransferase domain
of carbamoyl phosphate synthetase (22-24). Additionally, P5C was shown to form
adducts with other important metabolic intermediates including oxaloacetic acid, pyruvic
acid, and acetoacetic acid (25). Considering the outcomes of liberated P5C/GSA, there
appears to be a physiological advantage to sequester the intermediate during proline
catabolism.
Substrate channeling in PutA was first kinetically described in Salmonella
typhimurium (26); however, the structural and kinetic characterization of BjPutA have
made this enzyme the prototype of PutA channeling. An X-ray structure of BjPutA
revealed an irregularly-shaped cavity that spans 41 Å between the two active sites with a
total volume of 1400 Å3 (Figure 1) (10). The majority of the volume (1325 Å3) of the
tunnel comes from a large central chamber with dimensions 24 Å by 14 Å by 3-7 Å,
which provides adequate space to accommodate P5C (102 Å3) or GSA (120 Å3) (9).
Additionally, kinetic evidence comparing native BjPutA to an equal molar mixture of two
complementary active site mutants (R456M, no PRODH activity; C792A, no P5CDH
activity) showed the native enzyme immediately formed NADH, while the mixed variant
system had a significant lag phase before reaching steady state (10). Taken altogether,
substrate channeling of P5C/GSA in BjPutA is supported by strong kinetic and structural
evidence.
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Using the structural and kinetic knowledge of the channel, this work further
explores the cavity by mutating residues along the channel in an effort to obstruct P5C
movement between the active sites. A combination of kinetic and structural results
(through personal correspondence with Dr. John Tanner) provide evidence that
channeling can be hindered, but the location of the mutation along the channel seems to
be critical for impeding the intermediate. By making mutations along different parts of
the channel, we further define the channeling path and provide novel insights into how
P5C enters the channeling cavity.
MATERIALS AND METHODS
Chemicals
All chemicals were purchased from Sigma-Aldrich or Fisher Scientific unless
otherwise noted. E. coli strain BL21 (DE3) pLysS was purchased from Novagen, and
DH5α strain was purchased from Invitrogen. All experiments used Nanopure water.
Expression and Purification of BjPutA
PutA from Bradyrhizobium japonicum (BjPutA) was expressed as reported
previously, only the incubator temperature was decreased to 20 °C for 16 hours following
IPTG induction (27). Cells were harvested by centrifugation and frozen at -80°C.
Frozen cells were re-suspended in 50 ml binding buffer (20 mM Tris-base, 0.5 M NaCl, 5
mM imidazole, 10% glycerol, pH 7.9) and 100 µM flavin at 4°C. Protease inhibitors εamino-N-caproic acid (3 mM), phenylmethylsulfonyl fluoride (0.3 mM), leupeptin (1.2
µM), tosyl phenylalanyl chloromethyl ketone (48 µM), and tosyllysine chloromethyl
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ketone hydrochloride (78 µM) were added, and cells were disrupted via sonication. The
cell lysate was centrifuged for 1 h at 19,000 rpm in a JA-20 rotor (Beckman) and filtered
through a 0.2 µm filter (VWR). Cell-free lysate was loaded onto a Ni-NTA Superflow
resin (Qiagen) pre-equilibrated with binding buffer. Wash buffer (60 mM imidazole)
then elution buffer (500 mM imidazole) were applied to the column. Protein in the
elution fractions was then dialyzed into buffer containing 50 mM Tris (pH 7.5), 10 mM
NaCl, 0.5 mM EDTA, 10% glycerol and loaded onto an anion exchange column (HiTrap
Q HP column, GE Life Sciences) equilibrated with dialysis buffer (50 mM Tris, pH 7.5,
10 mM NaCl, 0.5 mM EDTA, 10% glycerol). A linear salt gradient comprised of
dialysis buffer and dialysis buffer containing 1 M NaCl was applied to elute the PutA
proteins. Purified PutA enzymes were then dialyzed into a final buffer containing 50 mM
Tris (pH 7.5), 50 mM NaCl, 0.5 mM EDTA, 0.5 mM Tris(3-hydroxypropyl)phosphine,
and 10 % glycerol. Enzyme concentrations were determined using 660 nm Protein Assay
(Pierce) and the amount of bound flavin was quantified (ε=13,620 M-1 cm-1) (27). The
concentrations of the PutA proteins were normalized to the concentration of bound flavin,
and the protein was flash-frozen in liquid nitrogen and stored at -80 °C.
Site-Directed Mutagenesis
Mutagenic primers (Table 1) were purchased from Integrated DNA Technologies or
Eurofins MWG Operon. GeneTailor Mutagenesis Kit (Invitrogen) was used to generate
all mutants except T348Y, which used a Quickchange II kit (Stratagene). Mutant
plasmids were transformed into DH5α cells, and resulting plasmids were sequenced by
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Eurofins MWG Operon to confirm mutations. Mutant BjPutA enzymes were expressed
and purified as described above.

Table 1. Primers used for site-directed mutagenesis
Mutant
T348Y

Primers
5’ GCGCCTATTGGGACTACGAGATCAAGCGCGCG 3’
5’ CGCGCGCTTGATCTCGTAGTCCCAATAGGCGC 3’

S607Y

5’ AGACGCTCGACGATGCGCTCTATGAGCTGCGCG 3’
5’ GAGCGCATCGTCGAGCGTCTTGCCGCCCTCG 3’

D778Y

5’ GCTGCCGGAGCAGGTCGCCTACGACGTTGTCACC 3’
5’ GGCGACCTGCTCCGGCAGCGCGGTGGCATCG 3’

D779A

5’ TGCCGGAGCAGGTCGCCGACGCCGTTGTCACCTCC 3’
5’ GTCGGCGACCTGCTCCGGCAGCGCGGTGGC 3’

D779W

5’ TGCCGGAGCAGGTCGCCGACTGGGTTGTCACCTCC 3’
5’ GTCGGCGACCTGCTCCGGCAGCGCGGTGGC 3’

D779Y

5’ CCGGAGCAGGTCGCCGACTACGTTGTCACCTCCGC 3’
5’ GCGGAGGTGACAACGTAGTCGGCGACCTGCTCCGG 3’

Steady-State Kinetic Assays
All steady-state assays were performed at 23 °C. Kinetic parameters for the
PRODH domain were determined for proline and ubiquinone (CoQ1) by following
reduction of CoQ1 at 278 nm (28). 50 mM potassium phosphate buffer (pH 7.5) and 0.5
µM enzyme were used in all kinetic assays. Km and kcat for proline were determined for
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all enzymes by varying proline (1-200 mM) while holding CoQ1 constant at 250 µM.
CoQ1 kinetic parameters were determined by varying CoQ1 (10-350 µM) while holding
proline constant at 150 mM. For both assays, data was collected on a Hi-Tech Scientific
SF-61DX2 stopped-flow instrument using a 0.15 cm pathlength. Initial velocities were
fit to the Michaelis-Menton equation using SigmaPlot 12.0.
Kinetic parameters of the P5CDH domain were determined for P5C/GSA and
NAD+. Kinetic constants for P5C/GSA were determined using exogenous D,L-P5C. D,L
P5C was synthesized according to the method of Williams and Frank, and the
concentration of D,L-P5C was determined as previously reported (29, 30). The
concentration of L-P5C is considered as half of the total D,L-P5C concentration. It
should be noted that D,L P5C is stored in 1 M HCl and it needs to be neutralized
immediately before use in the assays. This leads to high NaCl concentration of ~ 600 mM
after neutralization. Thus, all assays were performed with 600 mM NaCl to maintain
constant ionic strength. Km and kcat for P5C/GSA were determined by varying L-P5C
(0.01-6 mM) while holding NAD+ constant at 0.2 mM in 50 mM potassium phosphate
(pH 7.5, 600 mM NaCl) (0.25 µM enzyme). The effective concentration of GSA was
estimated from the P5C-GSA pH dependence experiment reported previously (22). To
determine kinetic parameters for GSA, NAD+ reduction was monitored at 340 nm (ε =
6200 M-1 cm-1), using a Powerwave XS 96 well plate reader (Biotek). The dissociation
constant for NAD+ was determined using intrinsic tryptophan fluorescence. Tryptophan
was excited at 295 nm and peak emission at 330 nm was recorded. Assays initially
included 50 mM potassium phosphate pH 7.5 and 0.25 µM enzyme, then NAD+ (0.1-25
µM) was titrated in, which quenched tryptophan fluorescence. The observed inner filter
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effect caused by the absorption of incident light by NAD+ at 295 nm was corrected using
equation 1 (28). Fcorr and Fobs are the corrected fluorescence and observed fluorescence,
and Aex and Aem are the absorbance values of NAD+ at the excitation and emission
wavelengths.
F  F 10

A +A
 ex em 
2

(1)

A dissociation constant for NAD+-BjPutA complex was determined by plotting the
fraction of BjPutA bound by NAD+ versus free [NAD+] using equation 2, where θ is the
fraction of NAD+ bound and n is number of binding sites.


[NAD ] 

d  [NAD+ ] 

(2)

The concentration of free NAD+ was determined using equation 3.
NAD+   [NAD+ ]  [BjPutA]
Θ is the fractional saturation of BjPutA and is calculated by

 

(3)

  ! 

, where F0 is

fluorescence intensity without NAD+, F is fluorescence intensity in the presence of
NAD+, and Fmax is the maximum fluorescence intensity under saturating concentrations of
NAD+.
Prior to performing these assays, the amount of NAD+ bound to purified BjPutA
was estimated by HPLC. Purified BjPutA was denatured with 5% vol/vol trichloroacetic
acid and centrifuged at 13,000 rpm for 5 min. Samples were then filtered with a 0.45
micron filter before being loaded into autosampler vials. Denatured BjPutA released
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both FAD and NAD+ cofactors, which were separated using a C18 column using 50 mM
potassium phosphate, pH 5.3 and 100% methanol. Method of solvent application was as
follows (flow rate 1 ml/min): 5 min isocratic elution with phosphate buffer, followed by
a 25 min linear gradient to 50% methanol, and finally a 5 min linear gradient to 75%
methanol. Both cofactors were detected at 280 nm. NAD+ eluted from the column at 7.9
minutes, while FAD eluted at 16.6 min. Finally, to determine NAD+ concentration, a
standard curve was established using NAD+ concentrations 10, 25, 50, 100, and 200 µM.
NAD+ standards were treated indentically to the BjPutA samples, i.e. 5% vol/vol
tricholoracetic acid. Peak areas of the standards were determined and fit to a linear
equation, then peak areas of NAD+ from BjPutA samples were used to calculate NAD+
concentration based on the linear fit of the standard curve. From this analysis, it was
estimated that 74% of BjPutA was complexed with NAD+. Thus, the NAD+ binding
experiments reported on the remaining 26% of BjPutA that purified without NAD+
bound.
Channeling Assays
Channeling assays that monitor the coupled PRODH-P5CDH reaction were used
to detect a lag phase in NADH formation when using proline as a substrate (10). A lag in
NADH formation indicates substrate channeling is not occurring. Channeling assays
were performed at 23°C by following NAD+ reduction at 340 nm (ε = 6200 M-1 cm-1) as
previously reported (10). Assay conditions and spectral corrections were carried out
identically to what was reported previously (10). All assays contained 0.1 mM CoQ1, 0.2
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mM NAD+, 40 mM proline, 50 mM potassium phosphate (pH 7.5), 25 mM NaCl, 10 mM
MgCl2, and 0.5 µM PutA enzyme.
Additional channeling assays were performed using increased concentrations of
D779Y and D779W. Assays contained 0.1 mM CoQ1, 0.2 mM NAD+, 40 mM proline, 50
mM potassium phosphate (pH 7.5), 25 mM NaCl, and 10 mM MgCl2. Reaction progress
curves were followed using a Cary Eclipse fluorescence spectrophotometer. NADH
formation was monitored by exciting at 340 nm and recording the emission at 460 nm.
D779Y and D778W concentrations of 0.187, 0.374, 0.935, and 1.87 µM were used in the
assays and compared to assays using 0.187 µM wild-type BjPutA.
Single Turnover Rapid-reaction Kinetics
Single turnover experiments were performed as described previously (10).
Briefly equal volumes of enzyme (21.3 µM wild-type, 17.8 µM T348Y, and 17.9 µM
D779Y) with 50 mM potassium phosphate (pH 7.5), 25 mM NaCl, 0.1 mM NAD+ was
rapidly mixed with 40 mM proline in 50 mM potassium phosphate buffer (pH 7.5), and
25 mM NaCl under anaerobic conditions (all concentrations reported as final
concentrations after mixing) (31). Anaerobic conditions were achieved by degassing
buffer, substrate, and enzyme solutions by performing repeated cyles of nitrogen flushing
and vacuuming. A day prior to performing the experiment, degassed buffer was imported
into an anerobic glovebox (Belle Technology), where it was combined with
protocatechuate dioxgenase (PCD) (0.05 U/mL) and protocatechuic acid (PCA) (100
µM), which help scrub dissolved oxygen. Buffer was then loaded into syringes and
sealed with parafilm before exporting from glove box. Stopped-flow mixing cell and
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tubing was thoroughly washed and incubated overnight with PCA/PCD buffer.
Immediately prior to performing the experiment, enzyme and substrate were degassed
and imported into the chamber, where PCA and PCD were added at concentrations
reported above. Both enzyme and substrate were loaded into syringes and wrapped with
parafilm before leaving the chamber. To collect data, anaerobic solutions were quickly
loaded onto the stopped flow and syringes were parafilmed. Spectra from 300-700 nm
were recorded using a Hi-Tech Scientific SF-61DX2 stopped flow instrument equipped
with a photodiode array detector. FAD (451 nm) and NAD+ (340 nm) reduction
reactions were extracted from the spectral traces and observed rate constants were
determined by single exponential fits as previously reported (10).
Kinetic Parameters of Alternative Substrates
Alternative P5CDH substrates were used to determine whether BjPutA mutants
D779Y and D779W exhibit higher activity with smaller substrates relative to larger
substrates. Kinetic assays using GSA, succinate semialdehyde, and propionaldehyde
were performed, and Km and kcat values for each were determined. All assays were
performed in buffer composed of 50 mM potassium phosphate (pH 7.5, 25 mM NaCl)
containing 0.2 mM NAD+ and variable concentrations of GSA (L-P5C 0.01-6 mM),
succinate semialdehyde (0.05-20 mM), and propionaldehyde (5-500 mM). Wild-type,
D779A, D779Y, and D779W concentrations varied in the assays for each of the
substrates. With GSA/P5C, all enzyme concentrations were 0.25 µM in the assays. For
succinate semialdehyde wild-type and D779A were 0.25 µM while D779W and D779Y
were 1 µM. For propionaldehyde, wild-type and D779A were 0.25 µM, D779W was 1
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µM, and D779W was 2 µM. All initial velocity data was collected on a Powerwave XS
96 well plate reader (Biotek). The data were fit to the Michaelis-Menten equation using
SigmaPlot 12.0.
RESULTS
Identification and Purification of Channeling Mutants.
The BjPutA crystal structure (PDB code: 3HAZ) and PyMOL plug-in CAVER
were used to identify tunnels within BjPutA (32, 33). With a starting point at the N5 of
the flavin cofactor, CAVER identified over twenty five channels leading to the bulk
solvent, with a handful extending from the N5, through the predicted internal cavity, and
past the catalytic cysteine in the P5CDH active site before exiting (Figure 1). By
analyzing these potential channels, several residues were identified that have side chains
that appear to orient into the channel at different points. These residues included T348,
S607, D778, and D779. As seen in Figure 1, the side chain of T348 extends towards a
bottleneck between the PRODH domain and the large internal cavity, while the side chain
of S607 points to a constriction between the cavity and the P5CDH domain. The side
chains of the last two residues, D778 and D779, appear to point into the main cavity.
The aforementioned residues were chosen for site-directed mutagenesis. Each
residue was substituted with a tyrosine in order to retain polarity while also increasing the
steric effect of the native side chain. Additionally, D779 also was mutated to tryptophan
and alanine. The tryptophan further increases side chain bulk and changes polarity,
whereas the alanine decreases steric size while also removing the functional property of
the side chain carboxylate. All six mutant proteins, T348Y, S607Y, D778Y, and
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Figure 1. Channel connecting the PRODH active site to the P5CDH active site. FAD is
shown bound within the PRODH domain, while NAD+ binds at the P5CDH domain. The
teal mesh channel connecting the two active sites indicates an area unoccupied by
electron density that extends from the PRODH domain to the P5CDH domain.
Presumably P5C travels through the channel from the PRODH active site to the P5CDH
active site. The magenta sticks are native residues that appear to orient into the channel
that were mutated to tyrosine residues. Numbers 1-4
4 label channels leading from bulk
solvent to the internal cavity. Channel 1 is where proline is believed to enter, channel 2
and 3 are potential entry/exit points for water or P5C, and channel 4 is where glutamate is
predicted to exit. This figure was prepared using PyMOL and CAVER using PDB code
3HAZ (32, 33).
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D779Y/W/A were purified and shown to have flavin spectra similar to wild-type BjPutA
with flavin peak absorbances at 380 and 451 nm. From the flavin absorbance spectra, the
percent bound flavin was estimated to be 74-99% per monomer for the mutants, which is
similar to 79% bound flavin for wild-type BjPutA.
Channeling Assays of BjPutA Mutants
To initially screen the mutants for disruption of the channeling event, coupled
PRODH-P5CDH channeling assays were performed. As described previously, these
assays report on the overall oxidation of proline to glutamate by monitoring NADH
formation (10). If an initial lag in NADH formation is apparent, then channeling is not
likely occuring. As shown in Figure 2, channeling assays were performed on wild-type
and all six BjPutA mutants. The progress curves of NADH formation in assays with
T348Y, S607Y, D778Y, and D779A are very similar to wild-type with no apparent lag.
The linear rate of NADH formation with the mutants is also similar to wild-type at
roughly 1.4 µM/min. In contrast, BjPutA mutants D779Y and D779W exhibit very little
NADH formation over the same time course. Minor amounts of NADH were detected
with D779Y and D779W even in assays extended out to 20 min. Assays were then
performed with higher concentrations of D779Y and D779W, and fluorescence
spectroscopy was used as a more sensitive technique to follow NADH formation. Figure
3 shows progress curves of NADH formation for D779Y and D779W relative to wildtype BjPutA. Increasing D779Y concentration 10-fold (0.187 µM to 1.87 µM) generates
NADH at rate comparable to wild-type BjPutA (0.187 µM) suggesting that D779Y is
about 10-fold less active than wild-type BjPutA (Figure 3A). The extrapolated lag time
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Figure 2. Channeling assays of wild
wild-type,
type, T348Y, S607Y, D778Y, D779A, D779Y, and
D779W. NADH formation was monitored at 340 nm for 10 minutes. Assays performed
using 40 mM proline, 100 µM ubiquinone (CoQ1), 200 µM NAD+, 50 mM potassium
phosphate, 25 mM NaCl, 10 mM MgCl2, pH 7.5
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Figure 3. Channeling assays with increasing concentrations of D779Y (A) and D779W
(B). NADH formation was monitored using fluorescence by exciting at 340 nm and
recording the emission
mission at 460 nm. In both plots 0.187 µM of wild-type
type enzyme was used
as a control, and four different concentrations of mutant were assayed (0.187-1.87
(0.187
µM) to
verify NADH formation. D779Y and D779W both significantly decrease NADH
formation rates, with the bulkier mutation having a greater impact.
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in NADH formation was 2.7 min for both wild-type and D779Y. In contrast to D779Y,
NADH was essentially undetectable using a 10-fold higher concentration of the D779W
mutant (Figure 3B). Thus, it appears that the D779W mutant is severely impaired.
If the channel was blocked in the D779Y and D779W mutants, P5C would be
expected to exit from the PRODH active site and build up in the bulk solvent. With P5C
concentration increasing in the bulk solvent over the time course of the reaction, P5C
would eventually bind to the P5CDH domain leading to NADH formation. This scenario
would reflect a non-channeling mechanism and would be characterized by a noticeable
lag phase in NADH formation. The significantly lower NADH formation observed with
D779Y and almost nonexistent NADH formation with D779W indicates that either
PRODH or P5CDH activity is significantly decreased or that P5C is unable to access the
P5CDH domain. To explore these possibilities, the kinetic parameters of the individual
PRODH and P5CDH domains were determined for the mutants. The mutants that
channeled similar to wild-type, especially D779A and T348Y, were used as channeling
controls throughout the rest of this work.
PRODH and P5CDH Kinetic Properties of BjPutA Mutants
The steady-state kinetic parameters of the PRODH domain were determined with
proline and CoQ1 as substrates (Table 2). Km and kcat values for proline (43 mM, 3.1 s-1)
and CoQ1 (105 µM, 2.9 s-1) were determined for wild-type BjPutA. Similar values
(within two-fold) were determined for all of the mutants except D778Y. D778Y
exhibited comparable Km values for proline (91 mM) and CoQ1 (82 µM), but kcat was
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nearly 9-fold
fold lower than wild
wild-type BjPutA. This result was unexpected as shown in
Figure 2 channeling assays, where D778Y exhibited a NADH formation rate that was
higher than the other mutants and wild
wild-type BjPutA. This indicates that even a 9-fold
9
decrease in PRODH activity is not significant enough to impact the overall PRODHPRODH
P5CDH coupled reaction rate. In summary, the kinetic parameters of the D779Y and
D779W mutants are similar to wild
wild-type
type BjPutA and demonstrate that the lower
channeling activity observed with these mutants is not caused by deficient PRODH
activity.
Kinetic parameters were also determined for the P5CDH domain in all of the
mutants. A Km value of 0.42 mM GSA was determined for wild-type BjPutA (Table 3).
All six mutants exhibited a simila
similar Km for GSA. The kcat values for wild--type BjPutA and
mutants T348Y, S607Y, D778Y, and D779A were similar and ranged from 3.4 – 5 s-1.
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Conversely, mutants D779Y and D779W had significantly lower kcat values of 0.02 s-1
and 0.003 s-1, respectively. These turnover rates are about 200-1000 fold slower than
wild-type BjPutA. The significantly lower P5CDH activity may be caused by disrupted
folding of the P5CDH domain or hindered passage of P5C to the P5CDH domain.
To explore the first possibility, NAD+ binding to BjPutA was confirmed by
determining the dissociation constant (Kd) of the NAD+-BjPutA complex using intrinsic
tryptophan fluorescence. Dissociation constants of all six mutants (0.8-1.6 µM) were
comparable to wild-type (0.6 µM). A Kd of 1.5 µM NAD+ was also determined for wildtype BjPutA by isothermal titration calorimetry, further validating the tryptophan
fluorescence results (Figure 4). These results imply that the P5CDH domain is
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Figure 4. Wild-type
type BjPutA disassociation constant of NAD+. 23.4 µM of BjPutA was
loaded into the sample cell, and 500 µM NAD+ was injected in 2 µll volumes for a total of
40 injections. N= 0.72. Kd = 1.5 µM.
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Table 3. P5CDH kinetic parameters
Glutamate-γ-Semialdehyde (GSA)

NAD+b

Enzyme

Km (mM)

kcat (s-1)

kcat/Km (M-1 s-1)

Kd (µM)

WT

0.42 ± 0.04

3.4 ± .12

8095 ± 822

0.60 ± 0.04

T348Y

0.42 ± 0.04

4.2 ± 0.15

10000 ± 1017

0.75 ± 0.06

S607Y

0.48 ± 0.03

4.5 ± 0.15

9375 ± 664

1.00 ± 0.04

D778Y

0.38 ± 0.02

3.8 ± 0.08

10000 ± 567

0.67 ± 0.04

D779A

0.38 ± 0.03

5.0 ± 0.14

13157 ± 1102

0.64 ± 0.05

D779Y

0.20 ± 0.03

0.02 ± 0.001

100 ± 15.8

0.65 ± 0.04

D779W

0.35 ± 0.15

0.003 ± 0.0005

8.6 ± 4.0

0.78 ± 0.05

a

0.01-6 mM P5C, 0.2 mM NAD+, 600 mM NaCl, 0.25 µM enzyme, 50 mM
potassium phosphate, pH 7.5

b

0.1-25 µM NAD+, 0.25 µM enzyme, 50 mM potassium phosphate, pH 7.5

folded properly in all of the mutants. Thus, it appears that the severe decrease in P5CDH
activity in D779Y and D779W is caused by structural effects in the channel that may
impede P5C movement.
Single Turnover Rapid-reaction Kinetics
From the above analysis, it appears that in the D779Y and D779W mutants, both
catalytic domains are folded properly but P5C is prevented from entering the P5CDH
domain. To test whether a single molecule of P5C could efficiently traverse the channel
in the D779Y mutant, a single turnover experiment was performed anaerobically without
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an electron acceptor for the flavin cofactor. In this experiment, enzyme and NAD+ are
rapidly mixed with proline and the absorbance spectrum from 700-300 nm is recorded
(Figure 5). From the spectra, NADH formation (340 nm) and flavin reduction (451 nm)
can be extracted and plotted as a function of time. Observed rate constants were
estimated by single exponential fits of both reductions and are reported in Table 4. The
observed rate constants for flavin reduction of wild-type and T348Y were 0.178 and
0.147 s-1, while D779Y was about 3-fold faster at 0.456 s-1. The rate of NADH formation
was similar between wild-type BjPutA and T348Y but was 10-fold slower (0.003 s-1) in
D779Y.

Table 4. Single turnover observed rate constants for BjPutA enzymes
BjPutA Enzyme

FAD Reduction kobs (s-1)

NADH Formation kobs (s-1) Lag Time (s)

Wild-type

0.178

0.033

1

T348Y

0.147

0.035

1.5

D779Y

0.456

0.003

11

The kobs values for flavin and NAD+ reduction for wild-type BjPutA and T348Y
are similar to that reported previously for BjPutA using the same assay conditions (0.20-1
and 0.025 s-1, respectively) (10). Additionally, Figure 5A and 5B show spectral traces for
wild-type and T348Y, where there is a 1 and 1.5 sec lag in NADH formation,
respectively. For D779Y shown in Figure 5C, the estimated lag time for NADH
formation is about 11 sec. The longer delay and slower rate of NADH formation in
D779Y is consistent with D779 being located at a point along the channel that is
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Figure 5. Single turnover rapid-reaction kinetic data for wild-type (A), T348Y (B), and
D779Y (C). PutA (21.3 µM wild-type, 17.8 µM T348Y, 17.9 µM D779Y) and 100 µM
NAD+ were rapidly mixed with 40 mM proline (all concentrations reported as final) and
monitored by stopped-flow multi-wavelength absorption (300-700 nm). Insets showing
FAD (451 nm) and NAD+ (340 nm) reduction versus time were each fit to a single
exponential equation to obtain the observed rate constant (kobs) of the respective
reduction. Note the inset in (C) is on a different time scale.
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narrower and thereby sensitive to large residue substitutions that potentially constrict the
cavity and impair channeling activity.
Alternative P5CDH Substrates
To further explore the narrowing of the cavity, smaller aldehyde substrates were
assayed for their ability to navigate the channel. Table 5 compares the kinetic parameters
of native substrate GSA (exogenous L-P5C), and smaller substrates succinate
semialdehyde and propionaldehyde. Succinate semialdehyde contains one less carbon
and no amino group, whereas propionaldehyde is a three carbon aldehyde. Table 5
compares the kcat/Km values of each substrate for wild-type, D779A, and channeling
mutants D779Y and D779W. To determine whether smaller substrates enter the P5CDH
domain more efficiently, the ratio of the kcat/Km of wild-type to the kcat/Km of each mutant
was determined and is reported in Table 5. Using GSA, succinate semialdehyde, and
propionaldehyde as substrates, D779A consistently reports a ratio close to one, indicating
all three substrates were channeled similarly to wild-type. D779Y and D779W had
kcat/Km values for GSA that were 81 and 941 fold lower than wild-type. However, when
using succinate semialdehyde, these ratios improved to 30 for D779Y and 38 for D779W.
If succinate semialdehyde was impaired to the same extent as the normal substrate, a 200fold decrease in kcat/Km would be expected. Instead, the kcat/Km values only decreased by
70 and 8-fold for D779Y and D779W, respectively. Because the reaction mechanism is
anticipated to be similar with succinate semialdehyde in all of the BjPutA enzymes, the
40-fold difference between wild-type BjPutA and D779Y/W indicates movement of
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succinate semialdehyde in the channel is impaired, but to a much lesser extent than
GSA/P5C. Propionaldehyde was shown to be an even poorer substrate for wild-type
BjPutA with a kcat/Km of 6.2 M-1s-1. The ratio of kcat/Km for D779Y and D779W were 34
and 115, respectively. Although still an improvement over GSA, they were not improved
relative to succinate semialdehyde. It should also be noted that propionaldehyde

Table 5. Alternative substrate kinetic comparisons
Glutamic Semialdehyde

Succinate Semialdehyde

kcat/ Km Ratio kcat/ Km
WT:MT
M-1s-1

Propionaldehyde

kcat/ Km Ratio
WT:MT

kcat/ Km
M-1s-1

kcat/ Km
Ratio
WT:MT

Enzyme

kcat/ Km
M-1s-1

WT

8095

--

42.2

--

6.2

--

D779A

13157

0.62

42.1

1

4.6

1.3

D779Y

100

81

1.4

30

0.18

34

D779W

8.6

941

1.1

38

0.054

115

All assays contained 0.2 mM NAD+, 50 mM potassium phosphate, 25 mM NaCl, pH 7.5

inhibited all four enzymes in a similar fashion (KI values between 123 and 234 mM),
suggesting D779Y and D779W are interrupting the channel and not disrupting the active
site. Taken together, these results indicate that, while smaller substrates do not retain
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activity of wild-type, there are marked improvements in the ability to reach the second
active site, especially in the larger mutant D779W.
DISCUSSION
Six mutations were made at three different points along the putative substrate
channel of BjPutA. Of the six mutations made, only D779Y and D779W appear to
disrupt P5CDH activity. Further kinetic results show that the PRODH and P5CDH
domains are folded properly, which is also confirmed by X-ray crystal structures of both
mutants (Tanner, personal communication). Finally, using smaller P5CDH domain
substrates appears to increase the efficiency of the P5CDH active site relative to wildtype, especially for the more bulky D779W mutation. The results of this study verify that
the cavity connecting the two active sites is used to shuttle P5C from the PRODH site to
the P5CDH site, and that blockage of the channel decreases P5CDH activity.
Three separate mutations were made at D779 that provide details about the
channel. First, mutating the aspartic acid to tyrosine dramatically decreases the catalytic
efficiency of GSA by over 80-fold. Adding more bulk in the form of a tryptophan
decreases the catalytic efficiency by over 940-fold, suggesting that larger residues at this
position have a great effect on channeling P5C/GSA. Conversely, the alanine mutant at
the same position displays similar kinetics at both active sites and channels similarly to
wild-type. Additionally, results with D779A show that loss of the carboxyl group did not
impact channeling, indicating charge at this location is not critical.
It is interesting to note that the position of the mutation along the channel is very
important for channel disruption. D778Y is adjacent to D779Y/W and crystal structures
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show it slightly orients into the cavity, though not enough to constrict the channel.
Consistent with the structural predictions, the D778 mutant channels similarly, if not
slightly better than wild-type. Additionally T348 and S607 appear to point into
bottleneck regions of the channel, but the tyrosine mutations do not affect activity at
either active site or the overall channeling reaction. In terms of T348Y and S607Y, we
cannot rule out that hydrogen bonding occurs between the tyrosine and either the
backbone or side chains of other local residues. Such an event would flatten the tyrosine
against the sidewall of the cavity rather than pointing into the channel and possibly
causing an obstruction.
One outstanding question that is answered in this study is how P5C/GSA accesses
the P5CDH active site. Previously it was unknown whether P5C/GSA exclusively used
the channel to enter the second catalytic site or whether it could enter directly from bulk
solvent. Experiments using D779Y and D779W with both exogenously added and
endogenously produced P5C showed decreased P5CDH activity. In channeling assays
using proline as a substrate, both D779Y and D779W showed very little NADH
formation (Figure 2). Likewise, using exogenous L-P5C to determine kinetic parameters
for the P5CDH domain revealed significantly lower kcat/Km values, predominantly due to
the large decreases in kcat. If P5C/GSA were able to enter the P5CDH active site from a
location other than the channel, the kinetic results would not have deviated from wildtype, especially when using exogenous P5C. It should be noted that both D779 mutants
bind NAD+ similarly to wild-type and crystal structures show no global disruptions in
protein folding (Dr. John Tanner, personal communication). Thus, the mutations did not
structurally change or perturb a P5C entry/exit point that may have been near the P5CDH

70

domain. Ultimately these results indicate that P5C must access the P5CDH domain using
the channel. It also suggests that if exogenous P5C is able to enter the cavity from a site
other than through the PRODH domain, it must do so upstream of the D779 residue.
A second elusive question in the PutA field is where and how hydrolysis of P5C
takes place. It has been proposed that the large internal cavity is large enough to house
several P5C and water molecules and may provide an environment for hydrolysis (9).
Based on the alternative substrate work using D779Y and D779W, it is tempting to
suggest that P5C-GSA equilibrium favors the cyclic P5C at the point of these mutations
in the channel. While succinate semialdehyde is missing a carbon and an amino group,
perhaps the channeling improvement is due more to the linearity of the substrate rather
than the shorter length. The larger D779W mutant shows nearly a 25-fold improvement
when comparing the wild-type: mutant kcat/Km ratios for GSA and succinate
semialdehyde. This may suggest the ringed structure is more sterically hindered than the
linear substrate, which is able to navigate the obstruction more efficiently. Based on the
structure, D779 is located within the first third of the channel, leaving plenty of room for
a hydrolysis reaction to occur downstream.
Making mutations along substrate channels is not new; other studies have
reported similar experiments to validate or expand understanding of substrate channeling.
Recently, two mutations were made along a surface crevice connecting two active sites in
the Arabidopsis bifunctional enzyme dethiobiotin synthetase (DTBS)-diaminopelargonic
acid aminotransferase (DAPAT-AT) (17). The crevice is thought to channel the
intermediate from DAPA-AT to DTBS. Mutants S360Y and I793W were made to
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obstruct the external crevice, and progress curves were monitored. The results showed
the mutations caused a lag time of 10-12 minutes, whereas wild-type experienced no such
lag, suggesting channeling of the intermediate was disrupted. Channel obstructions
(βC170F, βC170W) have also been made in tryptophan synthase, causing the rate of
intermediate channeling to slow10-fold in the phenylalanine mutant and over 1000-fold
in the tryptophan mutant (34). Steady-state and transient kinetic results indicated the
βC170W not only hindered passage of intermediate between active sites, but also affected
crosstalk between subunits (34). In both examples substrate channeling was disrupted by
placing bulky mutations along the channel, which provides precedence and validation for
the research reported here.
Finally, the structures presented here show a snapshot of a cavity connecting two
active sites, but it is necessary to think about the channel as being dynamic. It is well
known that PutA undergoes a conformational change upon flavin reduction, and it has
been proposed that a conserved ion pair (R456-E197) acts as a gate between the PRODH
domain and the main cavity (10, 35). These two examples illustrate how the overall
enzyme fluctuates, and it is reasonable that the topography of the channel changes as
well. Future structural studies of the enzyme at different points of catalysis may show
how the channel changes and could help further describe how P5C moves between active
sites.
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CHAPTER 3
Fusing the DNA
DNA-binding Domain of Escherichia
coli Proline Utilization A (PutA) onto the
Bifunctional PutA Enzyme from Rhodobacter
capsulatus Nearly Mimics a Genuine
Trifunctional PutA

Note: Results appearing in this chapter are being prepared for manuscript: Arentson,
Benjamin W., Farmer, Erin, Zhu, Weidong, Tanner, John J., Becker, Donald F. “Fusing
the DNA-binding
binding Domain of Escherichia coli Proline Utilization A (PutA) onto the
Bifunctional
al PutA Enzyme from Rhodobacter capsulatus Nearly Mimics a Genuine
Trifunctional PutA” manuscript in preparation.
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ABSTRACT
Proline utilization A (PutA) is a bifunctional flavoenzyme with proline
dehydrogenase (PRODH) and ∆1-pyrroline-5-carboxylate dehydrogenase domains that
catalyze the two-step oxidation of proline to glutamate. A subset of PutA proteins also
have an N-terminal ribbon-helix-helix (RHH) DNA-binding domain and are considered
trifunctional, such as PutA from Escherichia coli (EcPutA). EcPutA moonlights as an
autogenous transcriptional repressor of the put regulon and switches to a membranebound enzyme in response to cellular nutritional needs and proline availability. In this
work, we explored whether a trifunctional PutA could be engineered by fusing the RHH
DNA-binding domain of EcPutA onto the bifunctional PutA enzyme from Rhodobacter
capsulatus (RcPutA). The resulting EcRHH-RcPutA chimera was characterized along
with RcPutA and compared to EcPutA. RcPutA is shown to purify as a monomer
whereas EcRHH-RcPutA forms a stable dimer analogous to EcPutA. Despite unique
quaternary structures, RcPutA and EcRHH-RcPutA have comparable steady-state kinetic
parameters and show evidence of substrate channeling. In vitro assays show EcRHHRcPutA binds put control DNA and exhibits significantly increased lipid binding in the
presence of proline. These results are consistent with properties of EcPutA and mirror the
mechanism of EcPutA functional switching which is driven by proline-dependent
activation of membrane binding. EcRHH-RcPutA, however, is not observed to act as
transcriptional repressor in cell-based reporter assays. Thus, although EcRHH-RcPutA
displays characteristics of functional switching in vitro, it does not fully mimic the in vivo
properties of EcPutA.
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INTRODUCTION
The proline metabolic pathway converts proline into glutamate via two
consecutive steps catalyzed by proline dehydrogenase (PRODH) and ∆1-pyrroline-5carboxylate (P5C) dehydrogenase (P5CDH) (Scheme 1). In the first reaction, PRODH
forms the intermediate P5C through the flavin-dependent, two-electron oxidation of
proline. P5C then undergoes a non-enzymatic hydrolysis step, forming glutamate-γsemialdehyde (GSA), which is oxidized to glutamate by NAD+-dependent P5CDH. The
above central reactions of proline metabolism impact a broad array of physiological
processes in different organisms (1-4) and have underlying roles in human diseases such
as cancer (5, 6) and schizophrenia (7-9). Proline is also a critical respiratory substrate for
Helicobacter pylori during infection (10, 11) and in the fungal pathogen, Cryptococcus
neoformans, proline catabolism was recently shown to be required for virulence in mice
(12).
PRODH and P5CDH are separate enzymes in eukaryotes and Gram-positive bacteria,
whereas in Gram-negative bacteria the enzymes are encoded as a bifunctional
polypeptide known as proline utilization A (PutA) (13, 14). In addition to catalytic
activities, a subset of Gram-negative bacteria such as Escherichia coli and Salmonella
typhimurium encode PutAs with a DNA-binding domain, which allows PutA to bind
DNA and repress transcription of putA and putP (proline transporter) genes (15, 16). The
DNA binding domain in these so-called trifunctional PutAs provides a unique coupling
between proline availability and proline metabolic gene expression (15, 16).
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Scheme 1.. Reactions catalyzed by the bifunctional PutA enzyme. Proline dehydrogenase
(PRODH) domain catalyzes the conversion of proline to ∆1-pyrroline-5-carboxylate
carboxylate
(P5C) using a flavin cofactor as an electron acceptor. P5C undergoes a non-enzymatic
non
hydrolysis, resulting in glutamate
glutamate-γ-semialdehyde
semialdehyde (GSA). The P5C dehydrogenase
domain (P5CDH) catalyzes the NAD+-dependent
dependent oxidation of GSA to glutamate
glut
thereby
generating NADH
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In S. typhimurium and E. coli, PutA switches from a DNA-bound transcriptional
repressor to a membrane-bound enzyme based on intracellular proline levels and the
redox state of the flavin cofactor (16-18). Proline reduction of the flavin cofactor
significantly increases PutA membrane binding affinity while diminishing PutA-DNA
binding affinity by only two-fold (18-22). The DNA-binding domain of trifunctional
PutAs is located at the N-terminus and has been shown by X-ray crystallography to be a
ribbon-helix-helix (RHH) fold (15, 23, 24), whereas the membrane-binding domain of
PutA is not known. Recent studies of PutA from E. coli (EcPutA) have identified
conformational changes in the flavin cofactor and active site residues of the PRODH
domain that are critical for mediating redox activation of PutA membrane interactions.
Additionally, proline-dependent conformational changes occur outside the PRODH
domain, which correlate with increased PutA membrane binding (20). How
conformational changes in PutA enhance membrane interactions remains unclear.
Phylogenetic analysis of PutA proteins divides PutAs into two main branches. Branch
1 is composed of trifunctional and bifunctional PutAs whereas Branch 2 is composed
entirely of bifunctional PutAs (13, 14, 25). Trifunctional PutAs (Branch 1A) are
generally 1300 residues in length, which in addition to the PRODH and P5CDH domains,
contain a N-terminal DNA-binding domain and a C-terminal domain (CTD) of unknown
function (13, 14, 25). The bifunctional enzymes of Branch 1 can be subdivided into short
(~ 1000 residues) and long (~ 1200 residues) bifunctional PutAs (13, 14, 25). The best
characterized short bifunctional PutA (Branch 1A) is from Bradyrhizobium japonicum
(BjPutA), from which the first X-ray crystal structure of a full-length PutA was solved
(26). The X-ray crystal structure of BjPutA showed a dimer/tetramer oligomeric state
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and revealed a 40 Å cavity linking the PRODH and P5CDH domains (26). The cavity
allows channeling of the P5C intermediate between the two enzyme active sites. Long
bifunctional PutAs (Branch 1B) are more closely related to trifunctional PutAs in that
they contain the CTD of unknown function (13).
The aim of this study was to examine whether appending the DNA-binding domain of
EcPutA onto a long bifunctional PutA would generate a bona fide trifunctional PutA. For
this purpose, we chose to fuse the RHH domain of EcPutA (NCBI RefSeq NP_415534.1)
onto the N-terminus of the long bifunctional PutA from Rhodobacter capsulatus
(RcPutA) (NCBI RefSeq code YP_003578784.1, 1127 amino acids) to create an EcRHHRcPutA chimera. RcPutA and EcPutA are 47% identical (61% similar) between the
regions of the arm domain and the CTD of unknown function (Figure 1), making RcPutA
a suitable candidate for studying the effects of adding a N-terminal DNA-binding domain
(27). X-ray crystal structures of the EcPutA RHH domain (residues 1-47) show it is a
dimer that binds a 9-bp sequence, which is conserved in the put promoter regions of
Gram-negative bacteria that encode trifunctional PutAs (15). Figure 1 summarizes the
domain organization of EcPutA, RcPutA, and the resulting EcRHH-RcPutA chimera.
Here, we report the functional properties of RcPutA and the EcRHH-RcPutA chimera
and analyze the quaternary structures of these enzymes by analytical ultracentrifugation.
We show that RcPutA is a monomer and demonstrate that the RHH domain of EcPutA
induces dimerization of EcRHH-RcPutA. These results provide novel insights into the
diverse quaternary structures of PutAs. The RHH domain is also shown to promote
functional switching of RcPutA, however, other factors appear necessary for EcRHHRcPutA switching in vivo.
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Figure 1.. Domain organization maps of E. coli PutA, R. capsulatus PutA, and EcRHHEcRHH
RcPutA. The DNA-binding
binding domain (DBD) of E. coli PutA was fused immediately
upstream of R. capsulatus PutA, resulting in the EcRHH-RcPutA
RcPutA enzyme. Numbers
below the domain map indicate amino acid position. CCM, conserved C--terminal motif.
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MATERIALS AND METHODS
Materials
Unless noted, all chemicals were purchased from Sigma-Aldrich or Fisher Scientific.
Nanopure water was used in all experiments
Expression Constructs and Protein Purification
The putA gene from R. capsulatus was PCR amplified and inserted into a pET28
vector (Novagen) using NdeI and XhoI restriction sites. The EcRHH-RcPutA enzyme
was created by PCR amplification of the DNA-binding domain (residues 1-52) of EcPutA
from a pET14b-EcPutA construct described previously (28). NdeI restriction sites were
incorporated at both ends of the PCR product using primers 5’CGGCGCCATATGATGACCGACCTTTCCGCCCTTGG-3’ and 5’CGCCGCCATATGCTCCGGCAGAGTATCGCTGTTTTCC-3’. The PCR product was
then ligated into the pET28a-RcPutA construct immediately upstream of RcPutA gene
(NdeI and XhoI). The resulting pET28-EcRHH-RcPutA construct was confirmed by
DNA sequencing (Eurofins MWG Operon).
EcPutA was overexpressed and purified as previously described (21, 29). RcPutA
(1127 amino acids) and EcRHH-RcPutA (1180 amino acids), both in a pET28a vector,
were overexpressed in BL21(DE3) pLysS cells (Promega). Starter cultures (5 ml) were
grown overnight in LB medium (25 µg/ml kanamycin, 34 µg/ml chloramphenicol) and
used to inoculate 4-L cultures of LB medium plus antibiotics. Once cultures reached
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OD600 of 0.8, 0.5 mM IPTG was added, and cultures were grown overnight at 20°C
before harvesting by centrifugation and freezing the cell pellets at -80 °C.
The frozen cell pellets were resuspended in 50 ml binding buffer (20 mM Tris-base,
0.5 M NaCl, 5 mM imidazole, 10% glycerol, pH 7.9) at 4°C containing FAD (0.1 mM)
and protease inhibitors ε-amino-N-caproic acid (3 mM), phenylmethylsulfonyl fluoride
(0.3 mM), leupeptin (1 µM), tosyl phenylalanyl chloromethyl ketone (48 µM), and
tosyllysine chloromethyl ketone hydrochloride (78 µM). Cells were disrupted by
sonication at 4°C. The solubility of the proteins was optimized by adding 0.25 mM
Triton X-100 to the cell lysate and incubating at 4°C with slow stirring for 30 min. The
cell lysate was centrifuged for 1 h at 19,000 rpm in a JA-20 rotor (Beckman). The
supernatant was filtered (0.2 µm filter, VWR) and loaded onto a Ni2+ affinity column
(Superflow resin, Qiagen) equilibrated with Tris-base binding buffer (pH 7.9). Wash
buffer (Tris base with 60 mM imidazole) followed by elution buffer (Tris base with 500
mM imidazole) were then applied to the column. Elution fractions containing PutA
protein were then dialyzed overnight at 4°C into 50 mM Tris (pH 7.5) buffer containing
10 mM NaCl, 0.5 mM EDTA, and 10% glycerol. The protein was then loaded onto an
anion exchange column (HiTrap Q HP column, GE Life Sciences) equilibrated with the
Tris buffer above. A linear gradient of 0-1 M NaCl in Tris buffer (pH 7.5, 0.5 mM
EDTA, 10% glycerol) was used to elute PutA. Purified RcPutA and EcRHH-RcPutA
were then dialyzed into 50 mM Tris (pH 7.5) containing 50 mM NaCl, 0.5 mM EDTA,
and 10 % glycerol and stored at -80°C. Protein purity was analysed by SDS-PAGE.
Protein concentration was determined by the 660 nm Protein Assay (Thermo Scientific)
using bovine serum albumin as the standard. The amount of bound flavin adenine

84

dinucleotide (FAD) cofactor in purified RcPutA and EcRHH-RcPutA were determined as
previously described (17).

The N-terminal hexahistidine tag was retained after

purification.
PRODH Kinetic Assays
All steady-state assays were performed at 23°C. Kinetic parameters for proline were
determined using coenzyme Q1 (CoQ1) as an electron acceptor and monitoring CoQ1
reduction by the decrease in absorbance at 278 nm (ε = 14,500 M-1 cm-1) (29). Km and
kcat for proline were determined for RcPutA and EcRHH-RcPutA (0.25 µM) by varying
proline (0-100 mM) and fixing CoQ1 at 300 µM. Likewise, the Km and kcat for CoQ1 were
determined by varying CoQ1 (10-450 µM) while holding proline constant at 200 mM.
The above assays were conducted in 50 mM potassium phosphate (pH 7.5) and 25 mM
NaCl. Data was collected using a 0.15 cm pathlength on a Hi-Tech Scientific SF-61DX2
stopped-flow instrument. Kinetic parameters were determined by fitting initial velocities
to the Michaelis-Menton equation (SigmaPlot 12.0).
DNA-binding
The DNA-binding activity of the different proteins was determined by gel mobility
shift assays using fluorescently labeled put control DNA as previously described (23). A
dissociation constant of EcRHH-RcPutA with put control DNA was determined by bestfit analysis to eq 1 (Sigma Plot 12), where n is the number of binding sites and [L] is total
concentration of protein (17).
Fraction of DNA Bound  12L4/6d 7 2L4 (1)
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PRODH-P5CDH Coupled Assay
PRODH-P5CDH coupled activity, in which proline is converted to glutamate, was
measured for RcPutA and EcRHH-RcPutA as described previously (26). Briefly, 0.25
µM enzyme was mixed with 200 µM CoQ1, 40 mM proline, and 200 µM NAD+ in 50
mM potassium phosphate (pH 7.5) containing 25 mM NaCl. The progress of the reaction
was followed by NAD+ reduction at 340 nm (ε = 6200 M-1 cm-1).
Oligomeric Structure Determination
The oligomeric states of RcPutA and EcRHH-RcPutA were determined by gel
filtration chromatography and sedimentation equilibrium. The purified proteins were
loaded onto a Superdex 200 10/300 GL column (GE Life Sciences) and eluted by FPLC
in 50 mM Tris buffer (pH 7.5) containing 100 mM NaCl, 0.5 mM EDTA, and 10%
glycerol at a flow rate of 0.5 ml/min. The molecular weight of each protein was
determined using thyroglobulin (669 kDa), apoferritin (443 kDa), β-amylase (200 kDa),
bovine serum albumin (66 kDa), and carbonic anhydrase (29 kDa) as molecular weight
standards.
Sedimentation equilibrium was performed using an Optima XL-I analytical
ultracentrifuge (Beckman Coulter, Inc.) equipped with an eight-hole An50 Ti rotor.
RcPutA (2 mg/ml) and EcRHH-RcPutA (2 mg/ml) were dialyzed in 50 mM Tris buffer
(pH 7.5) containing 100 mM NaCl, 0.5 mM EDTA, and 5% glycerol. The dialyzed
proteins were then diluted to 0.2, 0.5, and 0.8 mg/ml and loaded at 110 µl each into the
sample cells. The reference cell was loaded (125 µl) with the dialysate buffer. Radial
scans with a spacing of 0.001 cm were collected at 280 nm at 22 and 24 h after
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equilibration at 8000 rpm. The scans are an average of 10 measurements at each radial
position. Origin 6.0 software was used to best-fit the data to a single ideal species model
using a solvent density of 1.018 g/ml and a partial specific volume of 0.742 ml/g
estimated from the RcPutA and EcRHH-RcPutA polypeptides by Sednterp software.
Membrane Interactions and Lipid Pull-down Assays
Membrane interactions of RcPutA and EcRHH-RcPutA were tested in vivo using an
E. coli BL21(DE3) strain that lacks PutA. A PutA deficient (putA-) E. coli strain of
BL21(DE3) was generated by disrupting the putA gene with a kanamycin cassette
(TargeTron Gene Knockout System, Sigma). The specific primers used were IBS 5’
AAAAAAGCTTATAATTATCCTTACGCCTCCCGCAGGTGCGCCCAGA
TAGGGTG 3’, EBS1d
5’CAGATTGTACAAATGTGGTGATAACAGATAAGTCCCGCA
GCC TAACTTACCTTTCTTTGT 3’and EBS2
5’TGAACGCAAGTTTCTAATTTCGGTTA
GGCGTCGATAGAGGAAAGTGTCT. The kanamycin cassette was introduced after
355 bp of putA gene. Subsequent PCR analysis of the putA gene showed a band of 547 bp
which contains 219 bp of the kanamycin cassette demonstrating the successful insertion
of the kanamycin cassette into the putA gene. Western blot analysis of cell lysates using
an antibodies generated against the RHH domain as previously described (30) confirmed
the lack of putA gene expression. The resulting BL21(DE3) putA- Kanr was then used for
testing functional membrane interactions of the different proteins. For these experiments,
EcPutA, RcPutA and EcRHH-RcPutA were subcloned into a pET21a vector (Novagen)
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by introducing NdeI and XhoI sites at the N-terminus and C-terminus, respectively, by
PCR. The following primers were used: EcPutA, (Fwd) 5’
CGGCGCCATATGGGAACCACCACCATGG-3’ and (Rev) 5’
CGGCGCCTCGAGTTAACCTATAGTCATTAAGC-3’; RcPutA, (Fwd) 5’
CGGCGCCATATGACCGACCTTTCCGCCC-3’, (Rev) 5’CGGCGCCTCGAGTCACCCGGCCAGCAAAGCCGC-3’; and EcRHH-RcPutA,
EcPutA Fwd and RcPutA Rev primers. A stop codon was placed upstream of the XhoI
site so that the PutA proteins were expressed without a histidine tag. The resulting
constructs EcPutA-pET21a, RcPutA-pET21a, and EcRHH-RcPutA-pET21a were
confirmed by DNA sequencing (Eurofins MWG Operon). The PutA constructs and
pET21a empty vector were transformed into BL21(DE3) putA- Kanr. Liquid cultures (5
ml) of cells containing the different constructs were grown in LB medium and cell lysates
were made to test for PutA protein expression. SDS-PAGE of total protein showed
equivalent expression levels of EcPutA, RcPutA, and EcRHH-RcPutA without (leaky
expression) and with IPTG (250 µM). To test for functional membrane interactions,
cultures were grown in LB medium to an OD600 of 0.5 and streaked on minimal agar
plates containing triphenyltetrazolium chloride (TTC) and proline (0.5%) or glycerol
(0.5%). Agar plates were made by autoclaving 0.7% K2HPO4, 0.3% KH2PO4, 0.01%
MgSO4, 0.2% protease peptone, 2.0% agar, then after cooling adding filter-sterilized
0.5% proline or 0.5% glycerol, 0.005% L-tryptophan, 0.0001% thiamine, and 0.0025%
triphenyl tetrazolium chloride (all wt/vol %).
Lipid pull-down assays were performed anaerobically under a nitrogen atmosphere in
a anaerobic chamber (Belle Technology Glovebox) as described previously using E. coli
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polar lipids (Avanti Polar Lipids) (31). In these assays 50 mM proline was used to
reduce the flavin cofactor in the PutA proteins (0.3 mg/ml) during the incubation with
lipid vesicles.
Cell-based Functional Switching Assays
EcPutA-pET21a, RcPutA-pET21a, and EcRHH-RcPutA-pET21a and pET21a empty
vector were transformed into E. coli strain JT31 putA- lacZ- containing putC:lacZ
(pUT03) as described previously (28, 31). Cells transformed with the various PutA
constructs were grown at 37°C in M9 minimal medium containing 0.005% L-tryptophan,
0.05% thiamine, 50 µg/ml ampicillin, 34 µg/ml chloramphenicol, 25 µg/ml kanamycin,
and 0, 0.1, and 15 mM proline. PutA expression was induced with 250 µM IPTG at
OD600 0.2 and cells were grown until OD600 0.8-1. β-galactosidase activity is reported in
Miller units (32) and was determined as previously described (31) except for the
following minor changes. Cells (500 µl) were diluted two-fold to 1 ml in Z buffer and
assays were run for 45 sec. Optical densities and absorbance readings were recorded
using a Biotek Powerwave XS plate reader (200 µl assays). Results are reported as an
average of four independent experiments.
RESULTS
General Properties and Steady-state Kinetic Parameters
RcPutA and EcRHH-RcPutA purified as soluble proteins with molecular sizes on
SDS-PAGE consistent with the predicted molecular weights of 119,460 Da (RcPutA) and
125,529 Da (EcRHH-RcPutA). The UV-visible spectra of the RcPutA and EcRHH-
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RcPutA were similar with maximum absorbance bands at 380 nm and 451 nm. Based on
the flavin absorbance spectra, the flavin content is 97% and 92% for RcPutA and
EcRHH-RcPutA, respectively.
The PRODH steady-state kinetic parameters for RcPutA and EcRHH-RcPutA were
determined and are reported in Table 1. The Km values for proline (5.6 mM) and CoQ1
(93 µM) in RcPutA are lower than that of EcPutA with the most significant difference
observed in the Km for proline. The kcat for RcPutA is also significantly lower than
EcPutA. However, the resulting kcat/Km values for RcPutA vary by only 2-3 fold from that
of EcPutA. For EcRHH-RcPutA, the kcat/Km of 167.9 M-1 s-1 with proline was the same as
RcPutA. When holding proline constant and varying CoQ1, a kcat/Km value of 6832 M-1s-1
was determined which is about two-fold lower than RcPutA. Overall, the PRODH steadystate kinetic parameters are similar for RcPutA and EcRHH-RcPutA with both enzymes
exhibiting a slower kcat than that of EcPutA. Thus, it appears that fusing the EcRHH
domain onto RcPutA does not significantly affect the PRODH kinetic parameters.
To further explore the kinetic properties of RcPutA and EcRHH-RcPutA, coupled
PRODH-P5CDH assays were performed. These assays report on the activity of both the
PRODH and P5CDH active sites by monitoring NADH formation, which is used as a
read-out of the overall conversion of proline to glutamate. Figure 2 shows a PRODHP5CDH coupled assay for RcPutA and EcRHH-RcPutA. The steady-state velocities of
NADH formation are similar for RcPutA and EcRHH-RcPutA under the assay
conditions, thus providing additional evidence that the fusion of the EcPutA DNAbinding domain does not disrupt the overall kinetic properties of RcPutA. In addition, no
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Figure 2. PRODH-P5CDH coupled activity assays of RcPutA and EcRHH-RcPutA.
Assays were performed using 200 µM CoQ1, 40 mM proline, 0.25 µM enzyme (RcPutA
or EcRHH-RcPutA) in 50 mM potassium phosphate (pH 7.5) and 25 mM NaCl. NADH
formation was monitored at 340 nm.

lag phase is apparent in these assays suggesting that the intermediate L-P5C/GSA does
not equilibrate with bulk solvent but instead is channeled between the PRODH and
P5CDH active sites (26). These results are consistent with that previously described for
BjPutA (26).
Oligomeric State Determination
The domain organization of RcPutA provides an excellent opportunity to explore the
impact of the RHH and CTD domains of EcPutA on the oligomeric organization of
PutAs. RcPutA has a conserved CTD but lacks the RHH DNA binding domain of
EcPutA. The oligomeric states of RcPutA and EcRHH-RcPutA were first analyzed by gel
filtration chromatography. Figure 3A shows a striking difference between the two
proteins. The elution profile of EcRHH-RcPutA estimates a molecular mass (M) of ~ 315
kDa whereas RcPutA elutes at an apparent M of ~ 122 kDa. These results indicate that
RcPutA purifies as a monomer whereas EcRHH-RcPutA is a dimer (~252 kDa) or a
trimer (~378 kDa) species.
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RcPutA and EcRHH--RcPutA
RcPutA were then analyzed by analytical ultracentrifugation.
Sedimentation equilibrium experiments were performed using three different protein
concentrations. The equilibrium data for RcPutA (Figure 3B) and EcRHH-RcPutA
EcRHH
(Figure 3C) were best-fit
fit to an ideal single
single-species
species model which yielded M values of 130
kDa (125.5 kDa theoretical) and 256 kDa (251 kDa theoretical), respectively. These
results confirm that RcPutA is a monomer and that EcRHH
EcRHH-RcPutA
RcPutA is a dimer,
suggesting
ting that the EcPutA RHH domain induces dimerization of RcPutA.
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Figure 3. Oligomeric structure analysis of RcPutA and EcRHH-RcPutA. (A) Gel
filtration elution profiles (monitored at 280 nm) of RcPutA (solid trace) and EcRHHRcPutA (dotted trace). (B) Sedimentation equilibrium analysis of RcPutA. Global fit
analysis of three different protein concentrations at 8000 rpm to an ideal single-species
model yielding a 130 kDa species (theoretical 126 kDa). (C) Sedimentation equilibrium
analysis of EcRHH-RcPutA. Global fit analysis of three different protein concentrations
at 8000 rpm to an ideal single-species model yielding a 256 kDa species (theoretical 251
kDa). A vertical offset was applied to the residuals which are shown for each fit in the
bottom panel. Molecular weight values are reported at a 95% confidence interval.
DNA-binding and Lipid Pull-down Assays of EcRHH-RcPutA
From the analysis above, it appears EcRHH-RcPutA adopts a similar oligomeric
state as that of EcPutA. We next sought to determine if EcRHH-RcPutA exhibited the
functional switching properties of EcPutA. The DNA-binding activities of EcPutA,
RcPutA, and EcRHH-RcPutA were compared using gel mobility shift DNA-binding
assays. Figure 4A shows that RcPutA does not bind DNA as expected whereas EcRHHRcPutA binds put control DNA similarly to EcPutA. A dissociation constant (Kd) for
EcRHH-RcPutA with put control DNA was determined by varying EcRHH-RcPutA
concentration in the binding assays as shown in Figure 4B. Figure 4C shows a plot of the
fraction of bound DNA versus EcRHH-RcPutA concentration fit to eq 1 (n = 1.2), from
which a Kd value of 39 ± 16 nM was estimated. This value is equivalent to that
determined previously for EcPutA (Kd = 45 nM) (17).
Lipid pull-down assays were used to test whether the membrane binding properties of
RcPutA and EcRHH-RcPutA are regulated by proline reduction of the flavin cofactor as
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observed for EcPutA (21, 31). RcPutA, EcRHH-RcPutA, and EcPutA were incubated
with E. coli polar lipid vesicles in the absence and presence of 50 mM proline. After
incubation for 1 h, the soluble and lipid fractions were separated by centrifugation and
analyzed by SDS-PAGE to monitor PutA partitioning in the soluble and lipid fractions.
Figure 5 clearly shows that in the absence of proline (i.e., oxidized state) RcPutA and
EcRHH-RcPutA are mainly in the soluble fraction similar to EcPutA. In the presence of
proline, RcPutA and EcRHH-RcPutA significantly partition into the lipid fraction,
indicating that membrane interactions are favored in a reducing environment as seen with
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Figure 4. DNA-binding
binding assays. (A) Gel mobility shift assays of EcPutA (200 nM),
RcPutA (200 nM), and EcRHH
EcRHH-RcPutA
RcPutA (200 nM) added to binding mixtures containing
2 nM of fluorescent labeled (IRdye
(IRdye-700 label) put control DNA (420 bp) and 100 ug/ml
of nonspecific calff thymus DNA. Free DNA and PutA
PutA-DNA
DNA complexes were separated
on a nondenaturing 4% polyacrylamide gel. (B) Representative gel mobility shift assay
with increasing concentrations (0
(0-400 nM) of EcRHH-RcPutA
RcPutA with fluorescently labeled
put control DNA (2 nM). (C) Plot of EcRHH-RcPutA
RcPutA concentration versus fraction of
DNA bound from two independent gel
gel-shift
shift assays. Data were fit to eq 1 to yield a
dissociation constant (Kd) of 39 ± 16 nM.
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Figure 5. Lipid pull-down
down assays. EcPutA, RcPutA, and EcRHH
EcRHH-RcPutA
PutA (0.3 mg/ml
each) were incubated with or without proline in HEPES buffer (pH 7.5, 150 mM NaCl)
with freshly prepared E. coli polar lipid vesicles (0.8 mg/mL) for 1 h at room
temperature. Following incubation, soluble and lipid fractions were separated by Air-fuge
ultracentrifugation and analyzed via SDS
SDS-PAGE.
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EcPutA. These results are consistent with redox functional switching of RcPutAmembrane associations as described previously for EcPutA.
Cell-based Testing of EcRHH-RcPutA Functional Switching
The assays described above show that EcRHH-RcPutA and EcPutA exhibit similar
properties suggesting that only the DNA binding domain of EcPutA is required to convert
RcPutA into a trifunctional protein. To confirm that EcRHH-RcPutA is a genuine
trifunctional protein, cell-based membrane interactions and transcriptional repressor
assays were performed. The ability of RcPutA and EcRHH-RcPutA to couple proline
utilization with the respiratory chain was tested in E. coli putA- cells on minimal medium
agar plates containing TTC, a redox dye that acts as an electron acceptor for
dehydrogenases and complex 1 at the membrane (33, 34). Figure 6A shows that plates
streaked with cells containing EcPutA, RcPutA, and EcRHH-RcPutA show a strong red
color, whereas cells containing the empty vector show only a faint red color after 20 h of
growth. These results indicate that EcRHH-RcPutA interacts functionally with the
membrane in vivo.
The ability of EcRHH-RcPutA to switch between DNA binding and membrane
binding was assessed using a cell-based β-galactosidase reporter assay as previously
described (28, 31). Figure 6B shows that β-galactosidase activity increases 3-fold in cells
containing EcPutA when proline is added to the growth media. This increase in βgalactosidase activity is similar to that which has been reported previously for EcPutA
(31). In cells with RcPutA, the β-galactosidase activity matched that of cells
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Figure 6. Cell-based
based functiona
functional switching assays. (A) In vivo membrane interaction
assays were performed with BL21DE3 PutA- KanR cells containing EcPutA, RcPutA,
EcRHH-RcPutA
RcPutA and pET
pET-21a
21a empty vector. Cells were plated on minimal media agar
containing proline and TTC and grown for 20 h at 37 °C.. The appearance of a red color
indicates utilization of proline as respiratory substrate and functional PutA-membrane
PutA
interactions.
tions. A control experiment using minimal media plus glycerol showed red
colonies for all four constructs (data not shown). (B) Cell
Cell-based
based transcriptional repressor
assays in E. coli strain JT31 putA- lacZ- cells containing the putC:lacZ reporter gene
plasmid
mid and EcPutA, RcPutA, EcRHH
EcRHH-RcPutA and the pET-21a
21a empty vector. Cells
were grown at 37 oC in minimal media supplemented with 0 mM, 0.1 mM, and 15 mM
proline. β-galactosidase
galactosidase activity is reported as the average of four independent
experiments ± standard errors.
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containing the empty vector with and without proline consistent with RcPutA not binding
put control DNA (Figure 6B) and thereby not being able to repress transcription of the
putC:lacZ reporter gene. Unexpectedly, cells containing EcRHH-RcPutA exhibited the
same level of β-galactosidase activity as RcPutA cells with and without proline. The high
levels of β-galactosidase activity in the absence of proline indicate that unlike EcPutA,
EcRHH-RcPutA does not repress transcription of the putC:lacZ reporter gene. Thus,
although EcRHH-RcPutA appears to have all of the properties necessary for functional
switching, the chimeric protein is unable to act as transcriptional repressor in vivo.
DISSCUSSION
Purification of RcPutA provided an opportunity to characterize a PutA enzyme with a
unique quaternary structure, which in contrast to BjPutA and EcPutA, purifies as
monomer. The CTD of RcPutA must interfere with the dimerization interface observed
previously for BjPutA. BjPutA is a shorter enzyme that lacks the CTD and was observed
by X-ray crystallography to form a dimer of dimers or a tetrameric species.(26) Relative
to EcPutA, RcPutA lacks the RHH-DNA-binding domain, which has also been shown to
be responsible for dimerization of EcPutA. Thus, RcPutA represents an intermediate
form between the two different dimeric species of BjPutA and EcPutA.
The observation that RcPutA follows a substrate channeling mechanism in the
coupled PRODH-P5CDH reaction indicates a dimeric structure is not required for
substrate channeling. The progress curve of the coupled PRODH-P5CDH assay is
consistent with substrate channeling, as no lag phase is detected indicating that the
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P5C/GSA intermediate is channeled from the PRODH active site to the P5CDH domain
in RcPutA. Substrate channeling is best characterized for BjPutA in which the X-ray
crystal structure of the full-length enzyme revealed a cavity linking the PRODH and
P5CDH active sites (26). In assays using a mixture of monofunctional variants of
BjPutA which lack either PRODH or P5CDH activity, a ~ 8 min lag was observed before
reaching steady-state formation of NADH thereby mimicking a non-channeling PRODHP5CDH coupled reaction (26). The progress curve of RcPutA and the EcRHH-RcPutA
clearly do not show a lag, which is consistent with a substrate channeling mechanism.
Discovering that the monomeric form of RcPutA does not prohibit substrate
channeling suggests another function for the CTD. The X-ray crystal structure of the
BjPutA showed a domain swap dimer is formed via the P5CDH domain (26). A β-flap
from each protomer forms strong interactions with the neighboring protomer in BjPutA
(26). This interaction not only helps stabilize the dimeric structure but also helps form
part of the cavity wall (26). It seems likely that the CTD of RcPutA must somehow
substitute for these domain swap interactions thus helping form the channel cavity while
stabilizing the P5CDH domain within the RcPutA monomer. An unexpected finding was
the enhanced membrane binding of RcPutA in the presence of proline. Previously,
BjPutA membrane-binding affinity was shown not to be increased by proline (35). Here,
the membrane-binding of RcPutA was significantly enhanced by proline similar to that of
EcPutA. This indicates a potentially important role of the CTD in the regulation of PutAmembrane interactions. The physiological rationale for regulating RcPutA membrane
interactions is not clear, as RcPutA does not have a transcriptional repressor function. In
R. capsulatus, putA expression is activated in response to proline by the PRODH
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activator, PutR (36). PutR contains a helix-turn-helix motif and is a member of the
Lrp/AsnC family of DNA binding proteins (36).
Fusing the EcRHH domain with RcPutA imparts in vitro DNA-binding activity in
EcRHH-RcPutA that is similar to EcPutA. In addition, EcRHH-RcPutA forms a stable
dimer providing further evidence that dimerization in trifunctional PutAs is mediated
through the DNA-binding domain (23, 37). The lipid-pull down assays show EcRHHRcPutA exhibits a strong increase in membrane binding consistent with EcPutA. Thus,
the in vitro characterization of EcRHH-RcPutA suggests that RcPutA has been
successfully converted into a trifunctional PutA protein. In the cell-based reporter assays,
however, we did not detect transcriptional repression of the putC:lacZ reporter gene nor
did we observe a proline-dependent increase in β-galactosidase activity. Because
EcRHH-RcPutA shows evidence of functional membrane interactions in the TTC assays
and no evidence for repression of the putC:lacZ reporter gene, we propose that the failure
of EcRHH-RcPutA to functionally switch in vivo is due to significantly weaker DNA
binding in the cell.
The inability of EcRHH-RcPutA to act as a transcriptional repressor in vivo was
unexpected. Previously, the EcRHH DNA-binding domain alone was shown to strongly
repress transcription of the putC:lacZ reporter gene in cell based assays (23, 31). Thus,
residues outside the RHH domain are not required for EcPutA transcriptional repressor
activity. Comparing the shape reconstructions generated by SAXS of EcPutA and
EcRHH-RcPutA may provide some insights into the lack of transcriptional repressor
activity in EcRHH-RcPutA.
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The reason EcRHH-RcPutA exhibits DNA-binding in vitro and apparently not in the
cell-based assay may be due to differences in DNA configuration. A relaxed linear DNA
fragment is used in the gel-mobility shift assays whereas in the cell-based assays the
putC:lacZ reporter gene is on plasmid DNA that is presumably supercoiled. The
supercoiled or condensed DNA structure may impact the accessibility of the put control
region to the EcRHH domain in EcRHH-RcPutA. In EcPutA, the spacing of the catalytic
lobes must be wide enough to allow the RHH domain to interact with different DNA
configurations. In EcRHH-RcPutA, the spacing is narrower, possibly restricting the
ability of the RHH domain to access condensed DNA. The structure of the EcRHHRcPutA dimer, however, allows the RHH domain to still interact with relaxed DNA. As a
result, fusing only the EcRHH domain onto RcPutA does not generate a fully
trifunctional protein. EcRHH-RcPutA shares many characteristics of EcPutA but fails in
the cell-based test of functional switching.
Comparison of the domain organization (Figure 1) between EcPutA and RcPutA
shows that EcPutA has a region of 34 amino acids (residues 49-86) that links the RHH
and arm domains. This linker region is not conserved in RcPutA and was not included in
the design of the EcRHH-RcPutA chimera. Whether this linker region is of structural
importance for stabilization and shape of the proposed DNA-binding cleft in EcPutA
remains unclear. It has previously been suggested that the aforementioned 34 residues are
involved in a hinge mechanism that can narrow or widen the DNA-binding cleft based on
global conformational changes caused by flavin reduction. From this study, it appears
that these 34 residues may indeed be critical for in vivo EcPutA DNA binding and
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EcPutA transcriptional repressor activity. Future studies will explore the role of the 34amino acid linker region in the functional switching mechanism of EcPutA.
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CHAPTER 4
Kinetic Exploration of the Proline
Dehydrogenase Active Sites of Geobacter
sulfurreducens Proline Utilization A and
Deinococcus radiodurans Proline
Dehydrogenase

Note: The GsPutA results presented in this chapter are currently part of a manuscript
and will be published alongside crystal structures.
The DrPRODH results have been published: Reproduced in part with permission
from (Luo,
Luo, M., Arentson, B. W., Srivastava, D
D.,
., Becker, D. F., and Tanner, J. J.
(2012) Crystal structures and kinetics of monofunctional proline dehydrogenase
provide insight into substrate recognition and conformational changes associated
with flavin reduction and product release, Biochemistry 51, 10099-10108).
10099
Copyright (2012) American Chemical Society.
http://pubs.acs.org/doi/abs/10.1021/bi301312f
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ABSTRACT
This chapter is divided into two sections. The first will kinetically explore the
proline dehydrogenase (PRODH) active site of Geobacter sulfurreducens PutA
(GsPutA), using a new ubiquinone analog menadione bisulfite. Additionally,
proline:ubiquinone oxidoreductase activity is shown to use a two-site ping pong
mechanism as previously reported in E. coli PutA. Finally a coupled channeling assay
was used to show that GsPutA channels P5C, verifying that all known PutAs to date
channel.
The second part of Chapter 4 will kinetically explore the monofunctional proline
dehydrogenase from Deinococcus radiodurans, revealing wild-type has a high Km for
proline. Additionally two highly conserved residues (G63A, E64A) were mutated and
kinetically characterized. Results indicate that Gly63 is important for the flexibility of
the β1-α1 loop, and Glu64 is important for stabilizing the closed active site.
Both sections are based on crystal structures generated by the lab of Dr. John J.
Tanner, University of Missouri-Columbia. Kinetic characterizations were performed to
help interpret structural evidence.
PART I: GsPutA Characterization
INTRODUCTION
Proline metabolism occurs through two enzymatic steps (1). First, the flavindependent proline dehydrogenase catalyzes the two electron oxidation of proline to ∆1pyrroline-5-carboxylate (P5C). P5C undergoes a non-enzymatic hydrolysis, which opens
the five-member ring and results in glutamate-γ-semialdehyde (GSA). GSA is a substrate
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for NAD+-dependent P5C dehydrogenase (P5CDH), which catalyzes a second two
electron oxidation to generate glutamate. In Gram-positive bacteria and eukaryotes
PRODH and P5CDH are expressed as separate enzymes; however, in Gram negative
bacteria the domains are fused into a single polypeptide called proline utilization A
(PutA) (2, 3).
The crystal structure of Bradyrhizobium japonicum (BjPutA) has been
determined, but it contains sulfate ions in both active sites and does not reveal how the
structure changes during catalysis (4). Recently however, several crystal structures of
minimalist PutA from Geobacter sulfurreducens were determined by Harkewal Singh of
the Tanner Lab (personal correspondence), revealing snapshots of different catalytic
states. In particular, a structure of the oxidized enzyme with no ligands bound
demonstrated for the first time a PutA in a resting state. Additionally, a GsPutA structure
with proline inhibitors THFA and lactate bound at the PRODH active site were the first
full length PutAs bound with proline analogs (personal correspondence). A structure
exhibiting the flavin-reduced state provided, for the first time, a structure of the PRODH
domain after release of P5C into the channel and before quinone binding (Tanner,
personal communication). Finally, a looming question in PutA biochemistry was
answered by a structure revealing the putative ubiquinone binding site.
N-propargylglycine (PPG) is a known mechanistic inhibitor of the PRODH active
site, where it reduces the flavin then becomes catalytically stuck through the formation of
a covalent bond between the active site lysine and N5 of the flavin (5). Using this
inhibitor, crystals with GsPutA locked into a reduced state were soaked with ubiquinone
analog menadione bisulfite (MB). MB was chosen both due to its high solubility in water
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and because menaquinones are the predominant respiratory quinones in Geobacter (6). A
subsequent structure revealed the binding site of MB, and presumably all quinone-based
flavin electron acceptors. As expected, the structure shows MB surrounded by several
non-polar and aromatic residues, including L147, L385, Y406, P408, Y309, and Y418
(personal correspondence). These residues provided points of mutation to potentially
disrupt the quinone binding site, so Gs L385A and Gs Y418A were made. Other
mutations to GsPutA were attempted, but solubility proved difficult. A second structure
of a minimalist PutA from Bdellovibrio bacteriovorus (BbPutA) was solved alongside
GsPutA, which also showed MB bound to the PRODH active site. Using the BbPutAMB complex, mutations Bb Y304A, Bb L380A, Bb Y401A, and Bb Y413A were made.
Of these mutations, only Gs Y418A, Bb Y413A, and Bb L380A will be discussed in this
chapter.
MATERIALS AND METHODS
Chemicals
All chemicals were purchased from Sigma-Aldrich or Fisher Scientific.
Nanopure water was used in all experiments. All enzymes were purified in the lab of Dr.
John J Tanner, University of Missouri-Columbia.
Steady State Kinetic Assays
All PRODH kinetic data was collected on a Hi-Tech Scientific SF-61DX2 model
stopped-flow spectrometer at 23 °C in 50 mM HEPES, 25 mM NaCl, pH 7.4 using 0.25
µM enzyme. For kinetic determinations, the reduction of ubiquinone (CoQ1) (ε = 14,500
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M-1 cm-1), menadione (ε = 14,000 M-1 cm-1) or MB (ε = 8,200 M-1 cm-1) was monitored at
wavelengths 278, 262 and 266 nm, respectively. Using GsPutA, the Km and kcat for CoQ1,
menadione, or MB were determined by varying CoQ1 (2.5-400 µM), menadione (2-400
µM), or MB (2.5-200 µM), while holding proline constant at 350 mM. Likewise the Km
and kcat for proline were determined by varying proline (10-750 mM), while holding
CoQ1 (300 µM), menadione (100 µM), or MB (150 µM) constant.
Using BbPutA, the Km and kcat of CoQ1, menadione, and MB were determined by
varying CoQ1 (2.5-500 µM), menadione (2.5-150 µM), or MB (2.5-250 µM), while
holding proline constant at 350 mM. The Km and kcat for proline were determined by
varying proline (1-350 mM), while holding CoQ1 (250 µM), menadione (100 µM), or
MB (100 µM) constant.
Three mutations at the putative ubiquinone binding site were made, L380A and
Y413A in BbPutA, and Y418A in GsPutA. All mutants were characterized using
variable proline (1-950 mM) while keeping menadione constant at 100 µM, or variable
menadione (0-200 µM) while holding proline at 350 mM. Enzyme concentration was
0.25 µM for L380A and Y413A for BbPutA and 2.5 µM for Y418A in GsPutA in all
assays.
P5CDH kinetic constants were determined by following NAD+ reduction at 340
nm, using a Powerwave XS microplate spectrophotometer (Bio-Tek). Assays consisted
of a buffer composed of 50 mM potassium phosphate, 25 mM NaCl, pH 7.5, where LP5C was varied (25-4000 µM), while holding NAD+ constant at 0.2 mM (0.75 µM
enzyme). The effective concentration of P5C and GSA at pH 7.5 was estimated as
previously reported (4, 7). All above initial velocity data was fit to the Michaelis-Menten
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equation using SigmaPlot 12.0.
Product Inhibition Assays
The proline:ubiquinone oxidoreductase mechanism was explored by determining
the product inhibition pattern of L-P5C, as previously reported (8). Briefly four different
concentrations of L-P5C (0, 0.5, 1.5, and 2.84 or 3 mM) were used while varying either
proline or MB. When varying proline (10-750 mM), 100 µM of MB was added (GsPutA
0.25 µM), and while varying MB (2.5-200 µM), proline was held at 250 mM (GsPutA 0.5
µM). The product inhibition pattern was also performed while varying proline (10-750
mM) in the presence of menadione (100 µM) to verify the natural electron acceptor has
the same inhibition pattern as MB (GsPutA 0.25 µM). Each data set was fit globally to
non-linear forms of the competitive, non-competitive, uncompetitive, and mixed
inhibition models, then best-fit models were reported.
Channeling Assays
Assays designed to detect a lag phase in the progress curve for the production of
NADH from proline were also performed. The observation of a lag phase in the progress
curve would be inconsistent with channeling. The channeling assay was performed on a
Cary 50 UV-Vis spectrophotometer in 50 mM potassium phosphate, 25 mM NaCl, pH
7.5 using 40 mM proline, 150 µM menadione, 0.2 mM NAD+, and 0.75 µM GsPutA.
Assays were performed in the presence and absence of NAD+, then progress curves were
subtracted to account for spectral interference of menadione at 340 nm. For comparison,
the progress curve for two non-interacting PRODH and P5CDH enzymes was simulated
using the free diffusion model described by equation 1 (9).
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[NADH] = v1t + (v1/v2)Km(e-v2t/Km -1)

(1)

In this equation, v1 is the rate of PRODH activity under the reaction conditions. The
parameters v2 and Km are the steady-state kinetic parameters for P5CDH activity of
GsPutA.
RESULTS AND DISCUSSION
Kinetic Characterization of GsPutA
Steady-state kinetic measurements were performed with MB and menadione to
verify that 1,4-naphthoquinones lacking an isoprenoid chain are electron acceptors of
GsPutA and to explore the mechanism of the oxidative half reaction (Table 1). The Km
and kcat values for MB at a fixed proline concentration of 350 mM are 10.5 µM and 0.66
s-1, respectively. Those of menadione are 8.2 µM and 0.97 s-1. The catalytic efficiencies
of the two quinones thus agree within a factor of two (60,000 M-1s-1 for MB and 120,000

Table 1. Steady-state kinetic parameters of GsPutA
Variable substrate

Fixed substrate

Km (µM)

kcat (s-1)

kcat / Km (M-1 s-1)

menadione bisulfite

proline*

10.5 ± 1.2

0.66 ± 0.018

62857 ± 7385

menadione

proline*

8.2 ± 0.89

0.97 ± 0.029

118292 ± 13317

proline

menadione bisulfite†

63010 ± 8047

0.85 ± 0.027

13.5 ± 1.8

89400 ± 12700

0.67 ± 0.027

7.5 ± 1.1

proline

†

menadione

*

Fixed proline concentration of 350 mM.
Fixed menadione concentration of 100 µM; fixed menadione bisulfite concentration of 150 µM.

†

M-1s-1 for menadione). Likewise, the kinetic constants for proline at a fixed quinone
concentration are similar (Table 1). These results show MB and menadione are efficient
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in vitro electron acceptors for GsPutA and suggest that the two quinones bind at the same
site on GsPutA.
Kinetic Mechanism of Proline:ubiquinone Oxidoreductase
In addition, the kinetic mechanism of the proline:ubiquinone oxidoreductase
activity was investigated, as EcPutA was recently reported to use a two-site ping-pong
mechanism when using CoQ1 as an electron acceptor (8). To verify that a two-site pingpong mechanism was also present when using MB in GsPutA, the product inhibition
pattern of L-P5C was explored. Using proline as a variable substrate, assays were
performed under different L-P5C concentrations to verify L-P5C competitively inhibits
proline when using MB as a flavin electron acceptor (Figure 1A). The same experiment
was performed using menadione as an electron acceptor also revealed L-P5C
competitively inhibits proline, further suggesting MB binds at the same site as menadione
(data not shown). Similarly MB concentrations were varied as L-P5C was held at
different concentrations, revealing L-P5C is an uncompetitive inhibitor of MB (Fig. 1B).
Taken together, the inhibition pattern of L-P5C parallels what is seen in EcPutA using
electron acceptor CoQ1, implying MB binds in the same fashion as CoQ1. Furthermore,
these results suggest all PutAs may use a two-site ping-pong mechanism when oxidizing
proline to L-P5C.
Coupled Channeling Assay
After determining GsPutA is kinetically active and displays a two-site ping pong
mechanism when using MB as an electron acceptor, a channeling assay was performed to
see whether GsPutA channels P5C between active sites. Initiating the coupled reaction
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Figure 1. Verification of proline:ubiquinone oxidoreductase kinetic mechanism by
determining the product inhibition pattern of L
L-P5C. (A) L-P5C
P5C vs proline. A non-linear
non
fit to a competitive inhibition model. Variable proline as L-P5C
P5C held at: closed circles 0
mM L-P5C,
P5C, open circles 0.5 mM L
L-P5C, closed triangles 1.5 mM L-P5C,
P5C, open triangles
2.84 mM L-P5C.
P5C. Best fit parameters were kcat = 0.30 ± 0.009 s-1, Km = 73.1 ± 8.8 mM
proline, and KI = 0.25 ± 0.03 mM L
L-P5C. (B) L-P5C vs MB. A non-linear
linear fit to an
uncompetitive model shown here as a Hanes
Hanes-Woolf
Woolf plot. Variable MB as L-P5C
L
held at:
closed circles 0 mM L-P5C,
P5C, open circles 0.5 mM L
L-P5C,
P5C, closed triangles 1.5 mM L-P5C,
L
open triangles 3 mM L-P5C.
P5C. Best fit parameters were kcat = 0.50 ± 0.01 s-1, Km = 12.9 ±
0.9 µM MB, and KI = 0.53 ± 0.025 mM L
L-P5C.
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with 40 mM proline, NADH formation was followed at 340 nm. Shown in Figure 2,
NADH formation occurs instantaneously at the start of the steady-state assay, which
suggests the occurrence of substrate channeling. Additionally a simulation using a free
diffusional model described by equation 1 was used to model a non-channeling PutA. In
equation 1, v1 is the rate of PRODH activity (2.78 µM min-1) using menadione as a flavin
electron acceptor, while v2 (5.6 µM min-1) and KmGSA (35.5 µM) are the steady-state
parameters of the P5CDH domain using exogenous L-P5C. Applying the above kinetic
parameters to equation 1, the dotted line in Figure 2 represents a progress curve of a nonchanneling PutA. A non-channeling PutA is predicted to display a lag phase with
transient time, τ, equal to the ratio of Km to V of the second enzyme, which is estimated at
6.3 minutes. Taken together, the data suggests the native enzyme channels based on the
lack of a lag phase in the native enzyme and the non-channeling simulation using native
steady-state rates.
BbPutA Proline:ubiquinone Oxidoreductase Activity
PRODH domain kinetic data using proline and three ubiquinone analogs was also
collected for BbPutA. Table 2 depicts kcat and Km of proline and ubiquinone analogs
CoQ1, menadione, and MB. GsPutA and E. coli PutA (EcPutA) are also shown as points
of comparison. Notably, when using CoQ1, menadione, or MB, BbPutA has a Km for
proline in the low millimolar range (1.0-6.9 mM), which is the lowest proline Km of any
PutA to date. Typically proline Km values using these analogs are in range of 30-70 mM,
as shown with EcPutA, BjPutA, and now GsPutA (4, 8).

Also, based on turnover

NADH Formation (µM)
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Native GsPutA
Non-channeling Simulation
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Figure 2. Channeling assay depicting the production of NADH from proline by GsPutA.
The solid curve represents NADH formation of native GsPutA, while the dashed curve
represents a simulation of non-interacting PRODH and P5CDH based on experimentally
determined kinetic values (equation 1). See text for experimentally determined values.
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number and catalytic efficiency, menadione is the preferred electron acceptor for flavin,
with well over a two-fold
fold increase in kcat over other analogs.
Ubiquinone Active Site Mutants
Using the above PRODH kinetic results, as well as the GsPutA crystal structure
with MB bound at the PRODH active site, two BbPutA mutants and one GsPutA mutant
were made in attempt to disrupt ubiquinone binding. Bb Y413A, Bb L380A, and Gs
Y418A were all made based on the GsPut
GsPutA
A and BbPutA crystal structures of the Dr. Jack
Tanner lab that showed these native residues interacting with or in close proximity to
bound MB. Multiple sequence alignments reveal these same residues are conserved in
EcPutA, as Gs Y418 and Bb Y413 align with Ec Y552.

Table 3. Kinetic parameters of Gs and Bb PutA Putative ubiquinone binding site mutants
Menadione
-1

Proline (Menadione)
-1 -1

-1

-1 -1

Enzyme

Km (µM)

kcat (s )

kcat/Km (M s )

Km (mM)

kcat (s )

kcat/Km (M s )

Bb WT

44.6

4.6

103139

6.9

3.0

434

119

L380A

60.9

1.7

27914

163

2.1

12.9

Y413A

14.5**

0.07**

4827**

--

--

0.044***

Gs WT

8.2

0.97

118292

89

0.67

7.5

Y418A

BD*

BD*

BD*

BD*

BD*

BD*

*Below detection limit.
** [Proline] is 350 mM, which is not saturating.
***Unable to saturate with proline (up to 950 mM)

The oxidoreductase activity of these mutants was characterized by determining
kinetic parameters using proline or menadione as a variable substrates (Table 3). In the
case of Bb L380A, the Km for menadione (44.6 µM) is similar to wild-type (60.9 µM);
however, the Km for proline is over 20-fold higher than wild-type at (163 to 6.9 mM),
suggesting proline binding is affected by this mutant.
Bb Y413A and Gs Y418A were also characterized. The Km for proline of Bb
Y413A was unable to be determined due to a lack of saturation even at nearly 1 M
proline, but the kcat/Km was calculated to be 0.044 M-1s-1, which is nearly 10,000 times
lower than wild-type. When determining kinetic parameters using menadione as a
variable substrate, the Km and kcat were unable to be successfully estimated because
proline was not at saturating levels. Similarly, kinetic data for the homologous residue in
GsPutA, Y418A, was unable to be collected due to a lack of activity, even at enzyme
concentrations of 2.5 µM. Taken together, all three mutants seem to have a marked
effect on proline binding, especially Bb Y413A and Gs Y418A.
While menadione binding was not directly affected by the active site mutations, it
is interesting to point out that the GsPutA crystal structures reveal both ubiquinone (MB)
and proline bind at the si face of the flavin (personal correspondence). Previous
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structural evidence suggests they also share active site residues, as Bb Y413 and Gs Y418
are homologous to E. coli Y552, which interacts with proline analog L-tetrahydro-2furoic acid (THFA) through van der Waals interactions (10, 11). Conversely, the
mechanism of the proline:ubiquinone oxidoreductase reaction was shown to be a two-site
ping-pong mechanism, suggesting proline and ubiquinone bind at separate sites.
However, these observations are both possible because the substrates associate with
different conformations of the enzyme. The GsPutA structures suggest proline binds and
the ion gate closes to sequester the active site, but when MB is bound the PRODH site
remains open. In this scenario, it is possible to share active site residues and still have a
two-site ping pong mechanism.
What the kinetic results do not convey is whether ubiquinone binding is affected,
especially in the case of Bb Y413A and presumably Gs Y418A. In BbY413 proline
binding is clearly affected, but we cannot conclude any definitive kinetic information
from menadione because menadione binding is dependent on proline oxidation. Further
studies to determine the menadione dissociation constant using wild-type and mutants
may provide insight into the effectiveness of the mutants in binding menadione.
Additionally, identifying residues that interact with menadione further from the proline
binding site may provide more kinetic support for the putative ubiquinone binding site.
SUMMARY
Kinetic characterization of GsPutA showed MB is a comparable substrate to
menadione, as menadione and MB have similar kinetic parameters. MB also was shown
to follow a two-site ping pong mechanism previously shown in EcPutA with CoQ1,
suggesting MB binds to the same site as other quinones. Ubiquinone binding mutants
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were inconclusive as to their effect on ubiquinone binding due to the weakened affinity of
proline to the enzyme. Finally, GsPutA was shown to channel P5C, which provides a
second kinetic and structural example of a channeling PutA.
PART II: DrPRODH Characterization
INTRODUCTION
The second project presented in this chapter involves the recently solved crystal
structure of Deinococcus radiodurans PRODH (DrPRODH) solved by Min Luo of the
Tanner Lab (12). The DrPRODH structure is of interest because the conformational
changes between the oxidized and reduced states of corresponding PRODHs and PutAs
have not been established structurally (though limited proteolysis experiments suggest
conformational change (13)). A structure of oxidized PutA (BjPutA) exists, but the
reduced structure does not (4). Likewise, the structure of TtPRODH has been determined
without substrate bound, but the substrate-bound reduced structure is unknown (14).
Structures both of oxidized and reduced DrPRODH bound by THFA were determined,
allowing conclusions to be made about conformational changes both within the active site
and peripherally in PRODH enzymes (12).
Interestingly, the oxidized structure displays flavin in two different
conformations, both of which bind THFA. In the THFA-bound reduced structure, the
flavin undergoes a large conformational change, going from a planar isoalloxazine to a
bent conformation, which has also been observed in E. coli PutA (15). However, unlike
the oxidized state, the flavin occupies a single conformation. Flavin reduction also
changes global protein conformation. One such change involves β1α1 loop (residues 62-
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69) and α8 helix (residues 285-295), which interact through ion pair R291-E64 in the
oxidized state (Figure 3). In the reduced state the linkage is ruptured, opening the active
site to solvent. Based on this observation, the β1α1 loop was explored. A well-conserved
glycine-glutamate motif (G63 and E64 in DrPRODH) seen in all monofunctional
PRODHs and PutAs was identified, and mutants G63A and E64A were made using sitedirected mutagenesis (14). Here Part II will explore the kinetic characterization of wildtype as well as these mutants, which will help draw conclusions regarding the

α8

Figure 3. Structure of DrPRODH depicting the conformational changes induced by

123

flavin reduction. A. Superimposed oxidized structure (yellow) and reduced structure
(grey), which shows the shift in helix 8 and the β1-α1 loop. Black dotted lines depict
electrostatic interactions of the oxidized structure. B. Surface representation of the
oxidized structure. FAD is show as yellow spheres, THFA shown as pink spheres. The
E64 and R291electrostatic interaction is shown in red and blue, respectively. C. Surface
representation of the reduced structure, where dashed lines indicate the opening in the
active site. Coloring is the same as B. Figure adapted from (12).
involvement of G63 and E64 in catalysis.
MATERIALS AND METHODS
Enzyme Activity Assays
All chemicals used during kinetic characterization were purchased from Fischer
Scientific or Sigma-Aldrich. All steady-state assays were conducted at 23 °C in 50 mM
potassium phosphate, 25 mM NaCl at pH 7.5. For all assays, Coenzyme Q1 (CoQ1) was
used as the electron acceptor with CoQ1 reduction monitored by the decrease in
absorbance at 278 nm using a molar extinction coefficient of 14.5 mM-1 cm-1 (8). The Km
for proline and kcat for wild-type DrPRODH (0.25 µM) were determined by varying the
concentration of proline (0 - 500 mM) while keeping CoQ1 constant (200 µM). Inhibition
of wild-type DrPRODH (0.25 µM) by THFA was analyzed by varying proline (10 - 500
mM) and THFA (0 - 200 mM), while keeping CoQ1 constant (200 µM). These assays
were performed in a total volume of 200 µl per assay using a Powerwave XS microplate
spectrophotometer (Bio-Tek). The Km for CoQ1 and kcat for wild-type DrPRODH (0.25
µM) were determined by varying CoQ1 (0 - 200 µM) and keeping proline constant (500
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mM). For the DrPRODH mutants G63A (11 µM) and E64A (6.3 µM), the Km for proline
and kcat were determined by varying proline (0 - 1000 mM) and holding CoQ1 constant
(200 µM). The Km for CoQ1 and kcat for the DrPRODH mutants were determined by
varying CoQ1 (10 - 450 µM) and holding proline constant (500 mM). These assays were
performed in a total volume of 150 µl by mixing enzyme and substrate solutions using a
Hi-Tech Scientific SF-61DX2 stopped flow instrument equipped with a 0.15 cm path
length cell. Steady-state parameters were calculated by fitting initial rate data to the
Michaelis-Menten equation and inhibition data were globally fit to a competitive
inhibition model using Enzyme Kinetic Wizard (SigmaPlot 12.0).
RESULTS AND DISCUSSION
The kinetic parameters for wild-type DrPRODH were first determined (Table 4).
The values of kcat and Km using proline as the variable substrate with fixed CoQ1 are 8.7 s1

and 290 mM, respectively, resulting in a kcat/Km of 30 s-1M-1. For comparison, the

corresponding parameters of the closely related TtPRODH (47% identical to DrPRODH)
are kcat = 13 s-1, Km = 27 mM proline (16). Those of the E. coli PutA are kcat = 5.2 s-1, Km
= 42 mM proline (8). Thus, the Km for proline of DrPRODH is higher than expected. The
kinetic parameters were also determined using CoQ1 as the variable substrate at fixed
proline concentration. These values are kcat = 14 s-1, Km = 155 µM. The corresponding
values for TtPRODH are not available. Those of the E. coli PutA are kcat = 3.4 s-1, Km =
110 µM CoQ1 (8). Finally, THFA was found to inhibit DrPRODH competitively with
proline. The estimated KI value of 38 mM is over 10 times higher than those of
TtPRODH (1 mM, (16)) and PutA (1.6 mM,(8)). These results suggest that the affinity
of DrPRODH for proline is atypically low. One explanation is the dual conformations of
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FAD in the active site. Perhaps one conformation is an inactive state that must undergo
conformational change in order to be active. Additional structures of the DrPRODH
enzyme could address this.
Catalytic activity is severely impaired in the mutants G63A and E64A (Table 4).
The kcat values of 0.08 s-1 and 0.055 s-1 for G63A and E64A, respectively, are over 100
times lower than that of DrPRODH. The catalytic efficiencies of G63A and E64A are
therefore 140-fold and 27-fold lower than that of DrPRODH. Using CoQ1 as the varying
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substrate, the kcat values are 0.043 s-1 and 0.046 s-1 for G63A and E64A, respectively.
These values are 300-fold lower than the kcat for DrPRODH. The kinetic analysis of
G63A and E64A confirms the significance of the conserved sequence motif and is
consistent with the structures, which suggest that Gly63 is important for the flexibility of
the β1-α1 loop, and Glu64 is important for stabilizing the closed active site.
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CHAPTER 5
Conclusions and Future Directions
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SUMMARY AND FUTURE DIRECTIONS
Proline metabolism has become an important area of study due to its involvement
in many different cellular processes from bacterial abiotic stress survival and
pathogenicity, to human tumor suppression and cellular redox control (1-6). This
dissertation sought to further knowledge of proline catabolism through kinetic
exploration of proline utilization A (PutA). First, substrate channeling was studied by
making bulky mutations along a cavity connecting the PRODH and P5CDH domains
(Chapter 2). Mutants D779Y and D779W showed a significant decrease in P5CDH
activity when compared to wild-type. To rule out mis-folded active sites, kinetic
parameters kcat and Km for the PRODH and P5CDH domains were obtained. The
PRODH kinetics for both mutants were similar to wild-type, suggesting the PRODH site
was unperturbed; however, the P5CDH domain kcat for D779Y (140-fold slower) and
D779W (1000-fold slower) were both significantly slower than wild-type. To distinguish
between P5C interacting with the P5CDH active site and a mis-folded P5CDH domain,
NAD+ dissociation constants were determined for all mutants. In all cases, the Kd values
for NAD+ aligned well with those of wild-type, suggesting P5C was not efficiently
arriving at the active site.
Next single-turnover reactions were performed to determine if P5C produced in
the PRODH domain was bottlenecked by the mutations, preventing movement to the
second active site. Results indicated that, even under single turnover conditions, D779Y
did not adequately transfer P5C through the channel. Together, these results all suggest
D779Y and D779W orient into the channel and hinder passage of P5C to the P5CDH
domain. Based on these results, other conclusions regarding the channel can also be
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made. Kinetic results indicate both exogenous P5C and endogenous P5C generated by
proline oxidation show decreased P5CDH activity in the mutants. This suggests that the
entry/exit point of P5C is upstream of the mutation, and P5C cannot enter the P5CDH
domain at the presumable NADH/glutamate entry/exit channel. This will be further
discussed below for future directions.
An additional experiment performed determined kinetic constants of alternative
substrates for the P5CDH domain. The hypothesis was that smaller substrates will be
able to better navigate the obstruction caused by mutants D779Y and D779W. The
D779Y/W kcat/Km of succinate semialdehyde and propionaldehyde were compared to
wild-type and were shown to improve when using smaller substrates. These results may
also suggest that the P5C-GSA equilibrium favors the ringed P5C at this point in the
channel, as linear substrate succinate semialdehyde appears to move through the channel
more efficiently.
To summarize, D779Y and D779W appear to impede passage of P5C to the
P5CDH domain, allowing conclusions discussed above to be drawn about the usage of
the channel. However, many questions still remain and will be targets of future
experiments. As outlined above, we know the channel is leaky, but where P5C enters and
exits remains a mystery. A future direction to answer this question involves mutant
A987Y, which appears to block a channel (Channel 2, Figure 1) to bulk solvent near the
D779Y/W mutation site. To determine if this is an entry exit point for P5C, mechanistic
inhibitor N-propargylglycine (PPG) will be used to inactive the PRODH domain (7).
Next P5CDH activity assays will be performed in the presence and absence of the
inhibitor and either wild-type or A987Y. From this experiment we will be able to
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determine whether exogenous P5C uses the same channel proline uses to access the
channel, or whether P5C uses the channel blocked by the A987Y mutation. Additional
work to determine the where the P5C/GSA hydrolysis takes place may also be possible,
especially with the work described above.
Chapter 3 discusses the creation of an artificial trifunctional PutA using long
bifunctional PutA R. capsulates and the DNA-binding domain of E. coli.
Characterization of this trifunctional PutA showed both PRODH activity and overall
channeling activity was similar to wild-type RcPutA. When determining DNA-binding
ability in vitro, the EcRHH-RcPutA enzyme had a similar disassociation constant to wildtype E. coli PutA. Additionally in vitro EcRHH-RcPutA interacted with the membrane in
the presence and absence of proline similar to E. coli PutA. When assaying the chimera
in cell-based assays, membrane interaction in the presence of proline showed similar
phenotypes to RcPutA and EcPutA; however, the chimera did not interact with DNA.
Although not presented in this dissertation, Dr. Jack Tanner’s group at University of
Missouri-Columbia determined small-angle X-ray scattering (SAXS) structure of the
chimera enzyme and found that it was a V-shaped dimer in solution, similarly to what
was previously reported for EcPutA (8). However, the EcRHH-RcPutA trench is not as
wide or as deep as EcPutA. This may be due to a shorter separation of the catalytic lobes,
meaning more EcPutA residues may be necessary to create a groove that resembles
EcPutA. As a future direction, we are currently working to add 34 additional EcPutA
residues to the DNA-binding domain. In EcPutA, the additional residues are part of a
linker region between the RHH domain and the arm domain. Performing a cell-based
assay with a DNA-binding domain containing the additional 34 residues will provide
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further structure-function knowledge of the DNA-binding portion of functional
switching.
Chapter 4 explores the kinetics of G. sulfurreducens PutA (GsPutA), the structure
of which was recently solved by the lab of Dr. Jack Tanner. Of great interest to PutA
biochemists are the different structures that were solved. Previously the only full length
PutA was that of BjPutA (9). As discussed in Chapter 4, the new structures provide
snapshots never before seen at different points of catalysis. Additionally, the ubiquinone
binding site was determined with ubiquinone analog menadione bisulfite bound at the si
face of flavin. In the work presented here, we verified menadione bisulfite was a
substrate of GsPutA through kinetic characterizations. Results indicated that it was a
substrate, having similar catalytic efficiencies to known substrate menadione. Following
substrate verification, the kinetic mechanism of the proline:ubiquinone oxidoreductase
activity was investigated. Previously it was shown that EcPutA uses a two-site ping-pong
mechanism when using CoQ1 as an electron acceptor. To verify menadione bisulfite uses
the same mechanism in GsPutA, product inhibition of L-P5C was explored. Results
indicated that GsPutA also uses a two-site ping-pong mechanism. Substrate channeling
was also studied in GsPutA. Channeling assays showed no lag in NADH formation,
while a simulation of non-interacting PRODH and P5CDH using experimentally
determined values showed a lag of 6.3 minutes. Finally of note, Chapter 4 contains
kinetic results for GsPutA, BbPutA, and EcPutA for flavin electron acceptors CoQ1,
menadione, and menadione bisulfite.
Future directions for GsPutA are many, as crystal structures reveal several
different snapshots of enzyme catalysis. It would be very interesting to look at changes
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in channel topography with respect to different stages of catalysis. Perhaps other tunnels
to bulk solvent become evident, or the channel constricts or expands during turnover.
The structures also revealed several channels from the cavity to the surface that
potentially can be blocked with mutagenesis to determine if they have a role in supplying
the cavity with water for hydrolysis of P5C/GSA or whether exogenous P5C can use the
tunnels for an entry-exit point.
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